<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="xp" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">xp</book-part-id>
      <title-group>
        <title>Xeroderma Pigmentosum</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kraemer</surname>
            <given-names>Kenneth H</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Dermatology Branch<break/>Center for Cancer Research<break/>National Cancer Institute<break/>Bethesda, Maryland</aff>
          <email>kraemerk@nih.gov</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>DiGiovanna</surname>
            <given-names>John J</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Dermatology Branch<break/>Center for Cancer Research<break/>National Cancer Institute<break/>Bethesda, Maryland</aff>
          <email>jdigiova@mail.nih.gov</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>20</day>
          <month>6</month>
          <year>2003</year>
        </date>
        <date date-type="updated">
          <day>29</day>
          <month>9</month>
          <year>2016</year>
        </date>
        <date date-type="revised">
          <day>14</day>
          <month>2</month>
          <year>2013</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="sedt" document-type="chapter">X-Linked Spondyloepiphyseal Dysplasia Tarda</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="xq28-dup" document-type="chapter">Xq28 Duplication Syndrome, Int22h1/Int22h2 Mediated</related-object>
      <abstract id="xp.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Xeroderma pigmentosum (XP) is characterized by:</p>
          <list list-type="bullet">
            <list-item>
              <p>Sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure in ~60% of affected individuals), with marked freckle-like pigmentation of the face before age two years in most affected individuals;</p>
            </list-item>
            <list-item>
              <p>Sunlight-induced ocular involvement (photophobia, keratitis, atrophy of the skin of the lids);</p>
            </list-item>
            <list-item>
              <p>Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma).</p>
            </list-item>
          </list>
          <p>Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, and progressive cognitive impairment). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of XP is made on the basis of clinical findings and family history and/or by the identification of biallelic pathogenic variants in <italic toggle="yes">DDB2, ERCC1,</italic>
<italic toggle="yes">ERCC2</italic>, <italic toggle="yes">ERCC3</italic>, <italic toggle="yes">ERCC4</italic>, <italic toggle="yes">ERCC5</italic>, <italic toggle="yes">POLH</italic>, <italic toggle="yes">XPA</italic>, or <italic toggle="yes">XPC</italic>.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Small, premalignant skin lesions such as actinic keratoses can be treated by freezing with liquid nitrogen; larger areas can be treated with field treatments such as topical 5-fluorouracil or imiquimod. Rarely, therapeutic dermatome shaving or dermabrasion has been used; skin neoplasms can be treated (as in persons without XP) with electrodesiccation and curettage, or surgical excision; skin cancers that are recurrent or in locations at high risk for recurrence are best treated with Mohs micrographic surgery. Oral isotretinoin or acitretin can prevent new skin neoplasms but have many side effects. Neoplasms of the eyelids, conjunctiva, and cornea can be treated surgically; corneal transplantation may improve the visual impairment resulting from severe keratitis. Hearing loss may be treated with hearing aids.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Avoid sun and other UV exposure to the skin and eyes; measurement of UV light with a light meter in an affected individual&#x02019;s home, school, and/or work environment so that high levels of environmental UV can be identified and eliminated.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Dietary supplementation with oral vitamin D as needed.</p>
          <p><italic toggle="yes">Surveillance:</italic> Skin examinations by a physician every three to 12 months; periodic routine eye and neurologic examinations and audiograms.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> UV exposure from sunlight and artificial sources of UV radiation, cigarette smoke.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> If family-specific pathogenic variants have been identified, molecular genetic testing of at-risk sibs can permit early diagnosis and rigorous sun protection from an early age.</p>
          <p><italic toggle="yes">Pregnancy management</italic>: Systemic retinoids (isotretinoin, acitretin) may be used as skin cancer chemopreventive agents. These drugs are known to be teratogenic to a developing fetus and pose a high risk for birth defects. Women of reproductive age who are taking a systemic retinoid must use effective contraception and be monitored with regular pregnancy tests.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>XP is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Once the pathogenic variants have been identified in an affected family member, carrier testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible options.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="xp.Diagnosis">
        <title>Diagnosis</title>
        <sec id="xp.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Xeroderma pigmentosum (XP) <bold>should be suspected</bold> in individuals with the following skin, eye, nervous system, and family history findings.</p>
          <p>
            <bold>Skin</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Acute sun sensitivity (severe sunburn with blistering or persistent erythema on minimal sun exposure)</p>
            </list-item>
            <list-item>
              <p>Marked freckle-like pigmentation (lentigos) on the face before age two years</p>
            </list-item>
            <list-item>
              <p>Skin cancer within the first decade of life</p>
            </list-item>
          </list>
          <p>
            <bold>Eye</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Photophobia with prominent conjunctival injection</p>
            </list-item>
            <list-item>
              <p>Severe keratitis, sometimes resulting in corneal opacification and vascularization</p>
            </list-item>
            <list-item>
              <p>Increased pigmentation of the lids with loss of lashes</p>
            </list-item>
            <list-item>
              <p>Atrophy of the skin of the lids resulting in ectropion, entropion, or in severe cases, complete loss of the lids</p>
            </list-item>
          </list>
          <p>
            <bold>Nervous system</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Diminished or absent deep tendon stretch reflexes. EMG and nerve conduction velocities may show an axonal (or mixed) neuropathy.</p>
            </list-item>
            <list-item>
              <p>Progressive sensorineural hearing loss. Audiometry may reveal early high-tone hearing loss.</p>
            </list-item>
            <list-item>
              <p>Acquired microcephaly. CT and MRI of the brain may show enlarged ventricles with thinning of the cortex and thickening of the bones of the skull.</p>
            </list-item>
            <list-item>
              <p>Progressive cognitive impairment</p>
            </list-item>
          </list>
          <p>
            <bold>Family history</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Consistent with autosomal recessive inheritance</p>
              <p>Note: Absence of a family history of XP does not preclude the diagnosis.</p>
            </list-item>
          </list>
        </sec>
        <sec id="xp.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of XP <bold>is established</bold> in a proband on the basis of clinical findings and family history (see <xref ref-type="sec" rid="xp.Suggestive_Findings">Suggestive Findings</xref>) and/or by the identification of biallelic pathogenic variants in one of the genes listed in <xref ref-type="table" rid="xp.T.molecular_genetic_testing_used_in_x">Table 1</xref>.</p>
          <p>Molecular testing approaches can include <bold>serial single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>.</p>
          <p><bold>Serial single gene testing<italic toggle="yes">.</italic></bold> The choice of which genes to analyze can be guided by the clinical features and the relative frequency in the population where the individual was born (see <xref ref-type="table" rid="xp.T.molecular_genetic_testing_used_in_x">Table 1</xref>, <xref ref-type="table" rid="xp.T.phenotype_correlations_by_gene_in_x">Table 2</xref>, <xref ref-type="fig" rid="xp.F1">Figure 1</xref>, and <xref ref-type="bibr" rid="xp.REF.digiovanna.2012.785">DiGiovanna &#x00026; Kraemer [2012]</xref>).</p>
          <p>Testing first for founder variants present in specific parts of the world may be considered:</p>
          <list list-type="bullet">
            <list-item>
              <p>
                <bold>
                  <italic toggle="yes">XPA</italic>
                </bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>India: c.335_338delTTATinsCATAAGAAA [<xref ref-type="bibr" rid="xp.REF.tamhankar.2015.16">Tamhankar et al 2015</xref>]</p>
                </list-item>
                <list-item>
                  <p>Japan: c.390-1G&#x0003e;C (carrier frequency of 1%) [<xref ref-type="bibr" rid="xp.REF.hirai.2006.171">Hirai et al 2006</xref>]</p>
                </list-item>
                <list-item>
                  <p>Tunisia: p.Arg228Ter [<xref ref-type="bibr" rid="xp.REF.messaoud.2010.883">Messaoud et al 2010</xref>]</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">XPC</italic>.</bold> North Africa: c.1643_1644delTG [<xref ref-type="bibr" rid="xp.REF.soufir.2010.1537">Soufir et al 2010</xref>, <xref ref-type="bibr" rid="xp.REF.hadjrabia.2013.1109">Hadj-Rabia et al 2013</xref>, <xref ref-type="bibr" rid="xp.REF.jerbi.2016.439">Jerbi et al 2016</xref>]</p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">ERCC2</italic>.</bold> Iraqi Jewish: p.Arg683Gln [<xref ref-type="bibr" rid="xp.REF.falikzaccai.2012.505">Falik-Zaccai et al 2012</xref>]</p>
            </list-item>
            <list-item>
              <p>
                <bold>
                  <italic toggle="yes">POLH</italic>
                </bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Tunisia / North Africa: Del exon 10 [<xref ref-type="bibr" rid="xp.REF.ben_rekaya.2014">Ben Rekaya et al 2014</xref>]</p>
                </list-item>
                <list-item>
                  <p>Japan: c.490G&#x0003e;T (splice site variant); p.Ser242Ter; p.Glu306Ter and c.1661delA [<xref ref-type="bibr" rid="xp.REF.masaki.2008.144">Masaki et al 2008</xref>]</p>
                </list-item>
                <list-item>
                  <p>Basque / Northern Spain: c.764+1G&#x0003e;A [<xref ref-type="bibr" rid="xp.REF.calmels.2016.26">Calmels et al 2016</xref>]</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">DDB2</italic>, <italic toggle="yes">ERCC1</italic>, <italic toggle="yes">ERCC2</italic>, <italic toggle="yes">ERCC3</italic>, <italic toggle="yes">ERCC4</italic>, <italic toggle="yes">ERCC5</italic>, <italic toggle="yes">POLH,</italic>
<italic toggle="yes">XPA</italic>, and <italic toggle="yes">XPC</italic> and other genes of interest (see <xref ref-type="sec" rid="xp.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included and the sensitivity of multi-gene panels vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
          <p>Fore more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
          <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">DDB2</italic>, <italic toggle="yes">ERCC1</italic>, <italic toggle="yes">ERCC2</italic>, <italic toggle="yes">ERCC3</italic>, <italic toggle="yes">ERCC4</italic>, <italic toggle="yes">ERCC5</italic>, <italic toggle="yes">POLH,</italic>
<italic toggle="yes">XPA</italic>, and <italic toggle="yes">XPC</italic>) fails to confirm a diagnosis in an individual with features of XP. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
          <table-wrap id="xp.T.molecular_genetic_testing_used_in_x" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Xeroderma Pigmentosum</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2" valign="middle" colspan="3" align="left" scope="colgroup" rowspan="1">Proportion of XP Attributed to Pathogenic Variants in This Gene&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by Test Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2" id="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">US</th>
                  <th headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2" id="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Japan</th>
                  <th headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2" id="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Europe</th>
                  <th headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3" id="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></th>
                  <th headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3" id="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">DDB2</italic>
                  </td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">3%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">3%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">15/15 alleles&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ERCC1</italic>
                  </td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_1 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_3" valign="middle" colspan="3" align="left" rowspan="1">Rare</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">4/4 alleles&#x000a0;<sup>8</sup></td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ERCC2</italic>
                  </td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">28%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">5%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">16%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;99%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ERCC3</italic>
                  </td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">1%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">0%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">2%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">8/8 alleles&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">ERCC4</italic>&#x000a0;<sup>10</sup></td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">0%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">7%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">3%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">~99%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">Rare&#x000a0;<sup>11</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ERCC5</italic>
                  </td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">3%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">1%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">9%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;99%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">POLH</italic>
                  </td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">7%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">25%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">13%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">25/40 alleles; 33/42 alleles&#x000a0;<sup>12</sup></td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">15/40 alleles; 9/42 alleles&#x000a0;<sup>12</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">XPA</italic>
                  </td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">9%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">55%&#x000a0;<sup>13</sup></td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">20%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">100%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">XPC</italic>
                  </td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">43%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">3%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_2 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">31%</td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">7/12 alleles&#x000a0;<sup>14</sup></td>
                  <td headers="hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_1_3 hd_h_xp.T.molecular_genetic_testing_used_in_x_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">5/12 alleles&#x000a0;<sup>14</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="xp.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="xp" object-id="xp.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="xp.TF.1.2">
                <label>2. </label>
                <p>Frequencies are taken from <xref ref-type="bibr" rid="xp.REF.bradford.2011.168">Bradford et al [2011]</xref> for 106 individuals with XP in the US, <xref ref-type="bibr" rid="xp.REF.moriwaki.2001.47">Moriwaki &#x00026; Kraemer [2001]</xref> for 291 individuals with XP in Japan, and <xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al [2016]</xref> for 89 affected individuals seen at a clinic in London, UK.</p>
              </fn>
              <fn id="xp.TF.1.3">
                <label>3. </label>
                <p>See <xref ref-type="sec" rid="xp.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="xp.TF.1.4">
                <label>4. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="xp.TF.1.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="xp.TF.1.6">
                <label>6. </label>
                <p><xref ref-type="bibr" rid="xp.REF.nichols.1996.24317">Nichols et al [1996]</xref>, <xref ref-type="bibr" rid="xp.REF.rapi_otrin.2003.1507">Rapi&#x00107;-Otrin et al [2003]</xref>, <xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al [2016]</xref></p>
              </fn>
              <fn id="xp.TF.1.7">
                <label>7. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available.</p>
              </fn>
              <fn id="xp.TF.1.8">
                <label>8. </label>
                <p><xref ref-type="bibr" rid="xp.REF.jaspers.2007.457">Jaspers et al [2007]</xref>, <xref ref-type="bibr" rid="xp.REF.kashiyama.2013.807">Kashiyama et al [2013]</xref></p>
              </fn>
              <fn id="xp.TF.1.9">
                <label>9. </label>
                <p><xref ref-type="bibr" rid="xp.REF.oh.2006.1092">Oh et al [2006]</xref>, <xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al [2016]</xref></p>
              </fn>
              <fn id="xp.TF.1.10">
                <label>10. </label>
                <p>Individuals with pathogenic variants in <italic toggle="yes">ERCC4</italic> have been reported with phenotypes of Fanconi anemia, XP/Cockayne Syndrome complex or with combined XP/CS/FA [<xref ref-type="bibr" rid="xp.REF.bogliolo.2013.800">Bogliolo et al 2013</xref>, <xref ref-type="bibr" rid="xp.REF.kashiyama.2013.807">Kashiyama et al 2013</xref>].</p>
              </fn>
              <fn id="xp.TF.1.11">
                <label>11. </label>
                <p>A deletion of exon 3 has been reported [<xref ref-type="bibr" rid="xp.REF.ahmad.2010.e1000871">Ahmad et al 2010</xref>].</p>
              </fn>
              <fn id="xp.TF.1.12">
                <label>12. </label>
                <p>The majority of reported <italic toggle="yes">POLH</italic> variants are detectable by sequencing; however, single and multiple exon deletions have been reported. The frequency of deletions varies by population [<xref ref-type="bibr" rid="xp.REF.broughton.2002.815">Broughton et al 2002</xref>, <xref ref-type="bibr" rid="xp.REF.opletalova.2014.117">Opletalova et al 2014</xref>]. Deletion of exon 10 accounted for 32/32 alleles in Tunisian patients with XP-V [<xref ref-type="bibr" rid="xp.REF.ben_rekaya.2014">Ben Rekaya et al 2014</xref>].</p>
              </fn>
              <fn id="xp.TF.1.13">
                <label>13. </label>
                <p>Common in Japan, rare in the US and Europe</p>
              </fn>
              <fn id="xp.TF.1.14">
                <label>14. </label>
                <p>
                  <xref ref-type="bibr" rid="xp.REF.chavanne.2000.1974">Chavanne et al [2000]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Test characteristics.</bold> See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v22/n7/full/ejhg2013233a.html">Clinical Utility Gene Card</ext-link> [<xref ref-type="bibr" rid="xp.REF.schubert.2014.22">Schubert et al 2014</xref>] for information on test characteristics including sensitivity and specificity.</p>
          <p><bold>Functional tests</bold> on living cells including cellular ultraviolet (UV) hypersensitivity, unscheduled DNA synthesis (UDS), and host-cell reactivation can be used to screen for abnormalities in DNA repair, but are not commonly available [<xref ref-type="bibr" rid="xp.REF.stefanini.2008">Stefanini &#x00026; Kraemer 2008</xref>, <xref ref-type="bibr" rid="xp.REF.kraemer.2012">Kraemer &#x00026; Ruenger 2012</xref>, <xref ref-type="bibr" rid="xp.REF.ruenger.2012">Ruenger et al 2012</xref>].</p>
          <p>Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="xp-Functional_tests.pdf" content-type="local-data">here</inline-supplementary-material> (pdf) for additional test options available on a research basis only.</p>
        </sec>
      </sec>
      <sec id="xp.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="xp.Clinical_Description">
          <title>Clinical Description</title>
          <p>The findings in 106 individuals with XP examined at the NIH in a long-term study from 1971 to 2009 by <xref ref-type="bibr" rid="xp.REF.bradford.2011.168">Bradford et al [2011]</xref> are summarized below. Citations from earlier studies are provided as well.</p>
          <p>
            <bold>Xeroderma pigmentosum (XP)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Cutaneous.</bold> Approximately 60% of individuals with XP have a history of acute sunburn reaction on minimal UV exposure. The other 40% of individuals with XP tan without excessive burning [<xref ref-type="bibr" rid="xp.REF.sethi.2013.1279">Sethi et al 2013</xref>]. In all individuals, numerous freckle-like hyperpigmented macules appear on sun-exposed skin. The median onset of the cutaneous symptoms is between ages one and two years [<xref ref-type="bibr" rid="xp.REF.kraemer.1987.241">Kraemer et al 1987</xref>, <xref ref-type="bibr" rid="xp.REF.kraemer.1994.1018">Kraemer et al 1994</xref>]. These abnormalities are limited to sun-exposed areas.</p>
              <p>Continued sun exposure causes the skin to become dry and parchment-like with increased pigmentation; hence the name xeroderma pigmentosum (&#x0201c;dry pigmented skin&#x0201d;). Most individuals with XP develop xerosis (dry skin) and poikiloderma (the constellation of hyper- and hypopigmentation, atrophy, and telangiectasia). Premalignant actinic keratoses develop at an early age. XP is an example of accelerated photo-aging. The appearance of sun-exposed skin in children with XP is similar to that occurring in farmers and sailors after many years of extreme sun exposure.</p>
            </list-item>
            <list-item>
              <p><bold>Ocular.</bold> Ocular abnormalities are almost as common as the cutaneous abnormalities [<xref ref-type="bibr" rid="xp.REF.kraemer.1987.241">Kraemer et al 1987</xref>, <xref ref-type="bibr" rid="xp.REF.kraemer.1994.1018">Kraemer et al 1994</xref>]. Findings may begin in the first decade of life and are usually limited to the anterior, UV-exposed portions of the eyes: conjunctiva, cornea, and lids [<xref ref-type="bibr" rid="xp.REF.dollfus.2003.107">Dollfus et al 2003</xref>, <xref ref-type="bibr" rid="xp.REF.brooks.2013.1324">Brooks et al 2013</xref>]. The benign conjunctival inflammatory masses that develop can spread to obscure the cornea. Epithelioma, squamous cell carcinoma, and melanoma of UV-exposed portions of the eye are common. The ocular manifestations may be more severe in black individuals [<xref ref-type="bibr" rid="xp.REF.dollfus.2003.107">Dollfus et al 2003</xref>, <xref ref-type="bibr" rid="xp.REF.ramkumar.2011.348">Ramkumar et al 2011</xref>, <xref ref-type="bibr" rid="xp.REF.brooks.2013.1324">Brooks et al 2013</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Neurologic.</bold> Progressive neurologic abnormalities that worsen slowly were reported in approximately 25% of 106 affected individuals [<xref ref-type="bibr" rid="xp.REF.rapin.2000.1442">Rapin et al 2000</xref>, <xref ref-type="bibr" rid="xp.REF.kraemer.2007.1388">Kraemer et al 2007</xref>, <xref ref-type="bibr" rid="xp.REF.digiovanna.2012.785">DiGiovanna &#x00026; Kraemer 2012</xref>, <xref ref-type="bibr" rid="xp.REF.lai.2013.4">Lai et al 2013</xref>, <xref ref-type="bibr" rid="xp.REF.totonchy.2013.194">Totonchy et al 2013</xref>, <xref ref-type="bibr" rid="xp.REF.viana.2013.1230">Viana et al 2013</xref>]. The onset may be early in infancy or, in some individuals, delayed until the second decade or later [<xref ref-type="bibr" rid="xp.REF.rapin.2000.1442">Rapin et al 2000</xref>]. The neurologic abnormalities may be mild (e.g., isolated hyporeflexia) or severe, with microcephaly, progressive intellectual impairment, sensorineural hearing loss beginning with high frequencies, spasticity, ataxia, and/or seizures. During an upper respiratory infection some individuals may develop difficulty swallowing or, rarely, vocal cord paralysis [<xref ref-type="bibr" rid="xp.REF.ohto.2004.222">Ohto et al 2004</xref>].</p>
              <p>The predominant neuropathologic abnormality found at autopsy in individuals with neurologic symptoms is loss (or absence) of neurons, particularly in the cerebrum and cerebellum. There is evidence for a primary axonal degeneration in peripheral nerves, in some cases with secondary demyelination [<xref ref-type="bibr" rid="xp.REF.rapin.2000.1442">Rapin et al 2000</xref>, <xref ref-type="bibr" rid="xp.REF.lai.2013.4">Lai et al 2013</xref>, <xref ref-type="bibr" rid="xp.REF.viana.2013.1230">Viana et al 2013</xref>].</p>
              <p>Reduced nerve conduction velocity may also be present on nerve conduction studies.</p>
            </list-item>
            <list-item>
              <p><bold>Cutaneous neoplasia.</bold> If aggressive UV avoidance is not begun early, accumulated sunlight-induced DNA damage is likely to result in skin cancer within the first decade of life. <xref ref-type="bibr" rid="xp.REF.bradford.2011.168">Bradford et al [2011]</xref> found that individuals with XP younger than age 20 years were at increased risk for the following cancers:</p>
              <list list-type="bullet">
                <list-item>
                  <p><bold>Non-melanoma (basal cell and squamous cell) skin cancer</bold> at UV-exposed sites. The &#x0003e;10,000-fold increased risk was associated with a median age of onset of nine years, nearly 60 years earlier than in the US general population.</p>
                </list-item>
                <list-item>
                  <p><bold>Cutaneous melanoma.</bold> The &#x0003e;2000-fold increased risk was associated with the median age of onset of 22 years, more than 30 years earlier than in the US general population.</p>
                </list-item>
                <list-item>
                  <p>Surprisingly, the persons with XP with the most severe sun sensitivity had a later onset of skin cancer &#x02013; probably because they used greater sun protection.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Other neoplasias.</bold> Review of the world literature has revealed a substantial number of people with XP who have oral cavity neoplasms, particularly squamous cell carcinoma of the tip of the tongue, a presumed sun-exposed location [<xref ref-type="bibr" rid="xp.REF.kraemer.1987.241">Kraemer et al 1987</xref>, <xref ref-type="bibr" rid="xp.REF.kraemer.1994.1018">Kraemer et al 1994</xref>, <xref ref-type="bibr" rid="xp.REF.butt.2010.534">Butt et al 2010</xref>].</p>
          <p>Gliomas of the brain and spinal cord, tumors of the lung, uterus, breast, pancreas, stomach, kidney, and testicles, and leukemia have been reported in a few individuals with XP [<xref ref-type="bibr" rid="xp.REF.digiovanna.1998.153">DiGiovanna et al 1998</xref>, <xref ref-type="bibr" rid="xp.REF.bradford.2011.168">Bradford et al 2011</xref>, <xref ref-type="bibr" rid="xp.REF.lai.2013.4">Lai et al 2013</xref>, <xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>].</p>
          <p>Because some of the carcinogens in cigarette smoke bind to DNA resulting in damage that is repaired by the nucleotide excision repair (NER) system, this unrepaired DNA damage may contribute to the development of lung cancer in individuals with XP. Overall, these reports suggest an approximate ten- to 20-fold increase in internal neoplasms in XP [<xref ref-type="bibr" rid="xp.REF.kraemer.1987.241">Kraemer et al 1987</xref>, <xref ref-type="bibr" rid="xp.REF.kraemer.1994.1018">Kraemer et al 1994</xref>, <xref ref-type="bibr" rid="xp.REF.bradford.2011.168">Bradford et al 2011</xref>].</p>
          <p><bold>Causes of death</bold>. The most common causes of death were skin cancer (34%, n=10); neurologic degeneration (31%, n=9); and internal cancer (17%, n=5). The median age at death (29 years) in persons with XP with neurodegeneration was younger than that in persons with XP without neurodegeneration (37 years) (p=0.02).</p>
        </sec>
        <sec id="xp.Phenotype_Correlations_by_Gene">
          <title>Phenotype Correlations by Gene</title>
          <p>For the overall clinical disorders (XP, Cockayne syndrome [CS], trichothiodystrophy [TTD], cerebrooculofacioskeletal [COFS] syndrome, and others [see <xref ref-type="fig" rid="xp.F1">Figure 1</xref>]), the clinical phenotypes are related within broad groups to the specific gene that is mutated (see <xref ref-type="fig" rid="xp.F1">Figure 1</xref> and <xref ref-type="table" rid="xp.T.phenotype_correlations_by_gene_in_x">Table 2</xref>).</p>
          <table-wrap id="xp.T.phenotype_correlations_by_gene_in_x" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Phenotype Correlations by Gene in XP and Related Disorders</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                  <th id="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Cutaneous Neoplasia</th>
                  <th id="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Phenotype</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">DDB2</italic>
                  </td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+&#x000a0;<sup>1</sup></td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">XP with no neurologic abnormalities</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ERCC1</italic>
                  </td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x02013;</td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">COFS syndrome&#x000a0;<sup>2</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_1" rowspan="5" valign="middle" align="left" scope="row" colspan="1"><italic toggle="yes">ERCC2</italic>&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">XP w/neurologic abnormalities ranging from none to severe</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">+</td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">XP/CS</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">+</td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">XP/TTD</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">-</td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">TTD</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">-</td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">COFS syndrome</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1"><italic toggle="yes">ERCC3</italic>&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">XP/CS</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">-</td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">TTD</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">+</td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">XP with mild neurologic abnormalities</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ERCC4</italic>
                  </td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">XP with no neurologic abnormalities or severe late-onset neurologic abnormalities&#x000a0;<sup>5</sup>; Fanconi anemia (FA)&#x000a0;<sup>6</sup>; 1 individual with features of XP, CS, and FA, and 2 individuals w/CS&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">ERCC5</italic>
                  </td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">XP w/no neurologic abnormalities or severe neurologic abnormalities</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">+</td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">XP/CS</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">POLH</italic>
                  </td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">XP w/no neurologic abnormalities&#x000a0;<sup>8</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">XPA</italic>
                  </td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">XP w/neurologic abnormalities ranging from mild to severe</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">XPC</italic>
                  </td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                  <td headers="hd_h_xp.T.phenotype_correlations_by_gene_in_x_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">XP w/no neurologic abnormalities&#x000a0;<sup>9,&#x000a0;10</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>COFS = cerebrooculofacioskeletal</p>
              </fn>
              <fn>
                <p>XP/CS = xeroderma pigmentosum-Cockayne syndrome complex</p>
              </fn>
              <fn>
                <p>XP/TTD = trichothiodystrophy with XP</p>
              </fn>
              <fn>
                <p>TTD = trichothiodystrophy (without XP)</p>
              </fn>
              <fn id="xp.TF.2.1">
                <label>1. </label>
                <p>Adults with large numbers of skin cancers have been reported [<xref ref-type="bibr" rid="xp.REF.oh.2011.785">Oh et al 2011</xref>, <xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>].</p>
              </fn>
              <fn id="xp.TF.2.2">
                <label>2. </label>
                <p>Only one person with COFS syndrome has been reported to have biallelic pathogenic variants in <italic toggle="yes">ERCC1</italic> [<xref ref-type="bibr" rid="xp.REF.jaspers.2007.457">Jaspers et al 2007</xref>]. One individual with a homozygous <italic toggle="yes">ERCC1</italic> pathogenic variant had severe Cockayne syndrome type II and died at age 2.5 years [<xref ref-type="bibr" rid="xp.REF.kashiyama.2013.807">Kashiyama et al 2013</xref>].</p>
              </fn>
              <fn id="xp.TF.2.3">
                <label>3. </label>
                <p>Individuals with XP caused by mutation of <italic toggle="yes">ERCC2</italic> (XP-D) have XP, XP with neurologic abnormalities, the XP/CS complex, TTD, or XP/TTD [<xref ref-type="bibr" rid="xp.REF.broughton.2001.2539">Broughton et al 2001</xref>, <xref ref-type="bibr" rid="xp.REF.lehmann.2001.15">Lehmann 2001</xref>, <xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>].</p>
              </fn>
              <fn id="xp.TF.2.4">
                <label>4. </label>
                <p><xref ref-type="bibr" rid="xp.REF.robbins.1974.221">Robbins et al [1974]</xref>, <xref ref-type="bibr" rid="xp.REF.weeda.1997.320">Weeda et al [1997]</xref>, <xref ref-type="bibr" rid="xp.REF.oh.2006.1092">Oh et al [2006]</xref>, <xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al [2016]</xref>.</p>
              </fn>
              <fn id="xp.TF.2.5">
                <label>5. </label>
                <p>Most individuals are from Japan. Several have been seen in UK [<xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>].</p>
              </fn>
              <fn id="xp.TF.2.6">
                <label>6. </label>
                <p>
                  <xref ref-type="bibr" rid="xp.REF.bogliolo.2013.800">Bogliolo et al [2013]</xref>
                </p>
              </fn>
              <fn id="xp.TF.2.7">
                <label>7. </label>
                <p>
                  <xref ref-type="bibr" rid="xp.REF.kashiyama.2013.807">Kashiyama et al [2013]</xref>
                </p>
              </fn>
              <fn id="xp.TF.2.8">
                <label>8. </label>
                <p>Individuals with XP variant are clinically identical to other individuals with XP with cutaneous symptoms without neurologic abnormalities [<xref ref-type="bibr" rid="xp.REF.inui.2008.2055">Inui et al 2008</xref>, <xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>].</p>
              </fn>
              <fn id="xp.TF.2.9">
                <label>9. </label>
                <p>&#x0201c;XP neurologic abnormalities&#x0201d; refers to progressive loss of motor, sensory, and cognitive function thought to result from neuronal loss.</p>
              </fn>
              <fn id="xp.TF.2.10">
                <label>10. </label>
                <p>Most individuals with XP caused by mutation of <italic toggle="yes">XPC</italic> (XP-C) have XP without XP neurologic abnormalities [<xref ref-type="bibr" rid="xp.REF.cleaver.1999.9">Cleaver et al 1999</xref>, <xref ref-type="bibr" rid="xp.REF.bradford.2011.168">Bradford et al 2011</xref>, <xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="xp.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>The study of genotype-phenotype correlations is ongoing. Further information is included in literature-based reviews and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v22/n7/full/ejhg2013233a.html">Clinical Utility Gene Card</ext-link> [<xref ref-type="bibr" rid="xp.REF.cleaver.1999.9">Cleaver et al 1999</xref>, <xref ref-type="bibr" rid="xp.REF.schubert.2014.22">Schubert et al 2014</xref>, <xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>].</p>
        </sec>
        <sec id="xp.Nomenclature">
          <title>Nomenclature</title>
          <p>Xeroderma pigmentosum was first described in Vienna by Moriz Kaposi in the textbook of dermatology he published in 1870 with his father-in-law, Ferdinand Hebra. The disorder was first called xeroderma or parchment skin. See discussion in <xref ref-type="bibr" rid="xp.REF.kraemer.1987.241">Kraemer et al [1987]</xref> and in <xref ref-type="bibr" rid="xp.REF.digiovanna.2012.785">DiGiovanna &#x00026; Kraemer [2012]</xref>.</p>
          <p>Previously, an individual with XP with any neurologic abnormality was said to have the DeSanctis-Cacchione syndrome. With clarification of the spectrum of XP disease, this term is now reserved for XP with severe neurologic disease with dwarfism and immature sexual development. The complete DeSanctis-Cacchione syndrome has been recognized in very few individuals; however, many individuals with XP have one or more of its neurologic features.</p>
          <p>&#x0201c;Pigmented xerodermoid&#x0201d; is now known to be identical to the XP variant.</p>
          <p>Before the genes responsible for XP were identified, complementation groups were used to categorize functional defects in affected individuals. In an XP complementation analysis cells from affected individuals were fused in the laboratory to determine whether their defects were different, in which case they would be able to supply all functions necessary to restore a normal cellular phenotype. Complementation is therefore a test of function and enabled the categorization of affected individuals as having the same or different defects. Subsequently, each complementation group was found to result from a defect in a distinct gene (<xref ref-type="table" rid="xp.T.xpassociated_genes_and_their_comple">Table 3</xref>). Testing to assign complementation group is currently not commercially available.</p>
          <table-wrap id="xp.T.xpassociated_genes_and_their_comple" orientation="portrait" position="anchor">
            <label>Table 3. </label>
            <caption>
              <p>XP-Associated Genes and Their Complementation Groups</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                  <th id="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Complementation Group&#x000a0;<sup>1</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">DDB2</italic>
                  </td>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">E</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ERCC1</italic>
                  </td>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">See footnote 2</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ERCC2</italic>
                  </td>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">D</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ERCC3</italic>
                  </td>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">B</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ERCC4</italic>
                  </td>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">F</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ERCC5</italic>
                  </td>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">G</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">POLH</italic>
                  </td>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Variant</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">XPA</italic>
                  </td>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">A</td>
                </tr>
                <tr>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">XPC</italic>
                  </td>
                  <td headers="hd_h_xp.T.xpassociated_genes_and_their_comple_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">C</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="xp.TF.3.1">
                <label>1. </label>
                <p>
                  <xref ref-type="bibr" rid="xp.REF.digiovanna.2012.785">DiGiovanna &#x00026; Kraemer [2012]</xref>
                </p>
              </fn>
              <fn id="xp.TF.3.2">
                <label>2. </label>
                <p>Previously called group H, a designation that was subsequently withdrawn</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="xp.Prevalence">
          <title>Prevalence</title>
          <p>Prevalence is estimated at 1:1,000,000 in the United States and Europe [<xref ref-type="bibr" rid="xp.REF.kleijer.2008.744">Kleijer et al 2008</xref>].</p>
          <p>Certain populations have a higher prevalence:</p>
          <list list-type="bullet">
            <list-item>
              <p>In Japan prevalence is estimated at 1:22,000 [<xref ref-type="bibr" rid="xp.REF.hirai.2006.171">Hirai et al 2006</xref>].</p>
            </list-item>
            <list-item>
              <p>In North Africa (Tunisia, Algeria, Morocco, Libya, and Egypt [<xref ref-type="bibr" rid="xp.REF.ben_rekaya.2009.426">Ben Rekaya et al 2009</xref>, <xref ref-type="bibr" rid="xp.REF.messaoud.2010.883">Messaoud et al 2010</xref>, <xref ref-type="bibr" rid="xp.REF.soufir.2010.1537">Soufir et al 2010</xref>] and the Middle East (Turkey, Israel, and Syria) [<xref ref-type="bibr" rid="xp.REF.kraemer.1985.33">Kraemer &#x00026; Slor 1985</xref>, <xref ref-type="bibr" rid="xp.REF.jerbi.2016.439">Jerbi et al 2016</xref>] prevalence is increased, especially in communities in which consanguinity is common.</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="xp.Genetically_Related_Allelic_Disorders">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>In addition to XP phenotypes discussed in this <italic toggle="yes">GeneReview</italic>, pathogenic variants in the genes causing XP are associated with the phenotypes cerebrooculofacioskeletal (COFS) syndrome, Cockayne syndrome, Fanconi anemia (FA), trichothiodystrophy (TTD), and XFE progeroid syndrome (<xref ref-type="fig" rid="xp.F1">Figure 1</xref>).</p>
        <table-wrap id="xp.T.allelic_disorders" orientation="portrait" position="anchor">
          <label>Table 4. </label>
          <caption>
            <p>Allelic Disorders</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_xp.T.allelic_disorders_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">XP-Related Gene</th>
                <th id="hd_h_xp.T.allelic_disorders_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Allelic Disorder</th>
                <th id="hd_h_xp.T.allelic_disorders_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Clinical Features</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_xp.T.allelic_disorders_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">ERCC2</italic>
                  <break/>
                  <italic toggle="yes">ERCC5</italic>
                </td>
                <td headers="hd_h_xp.T.allelic_disorders_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Cerebrooculofacioskeletal syndrome (Pena-Shokeir syndrome, type II; OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS214150">PS214150</ext-link>)</td>
                <td headers="hd_h_xp.T.allelic_disorders_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See <xref ref-type="sec" rid="xp.Differential_Diagnosis">Differential Diagnosis</xref></td>
              </tr>
              <tr>
                <td headers="hd_h_xp.T.allelic_disorders_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">ERCC1</italic>&#x000a0;<sup>1</sup><break/><italic toggle="yes">ERCC4</italic>&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_xp.T.allelic_disorders_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="cockayne" document-type="chapter">Cockayne syndrome</related-object>
                </td>
                <td headers="hd_h_xp.T.allelic_disorders_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See <xref ref-type="sec" rid="xp.Differential_Diagnosis">Differential Diagnosis</xref></td>
              </tr>
              <tr>
                <td headers="hd_h_xp.T.allelic_disorders_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">ERCC4</italic>
                </td>
                <td headers="hd_h_xp.T.allelic_disorders_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="fa" document-type="chapter">Fanconi anemia</related-object>
                </td>
                <td headers="hd_h_xp.T.allelic_disorders_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Heterogeneous condition characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy</td>
              </tr>
              <tr>
                <td headers="hd_h_xp.T.allelic_disorders_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">ERCC3</italic>
                  <break/>
                  <italic toggle="yes">ERCC2</italic>
                </td>
                <td headers="hd_h_xp.T.allelic_disorders_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Trichothiodystrophy (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS601675">PS601675</ext-link>)</td>
                <td headers="hd_h_xp.T.allelic_disorders_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See <xref ref-type="sec" rid="xp.Differential_Diagnosis">Differential Diagnosis</xref></td>
              </tr>
              <tr>
                <td headers="hd_h_xp.T.allelic_disorders_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">ERCC4</italic>
                </td>
                <td headers="hd_h_xp.T.allelic_disorders_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">XFE progeroid syndrome (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/610965">610965</ext-link>)</td>
                <td headers="hd_h_xp.T.allelic_disorders_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See footnote 2</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="xp.TF.4.1">
              <label>1. </label>
              <p>Two individuals with Cockayne syndrome and one individual with phenotypic features of Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia were described who had biallelic pathogenic variants in either <italic toggle="yes">ERCC1</italic> or <italic toggle="yes">ERCC4</italic> [<xref ref-type="bibr" rid="xp.REF.kashiyama.2013.807">Kashiyama et al 2013</xref>].</p>
            </fn>
            <fn id="xp.TF.4.2">
              <label>2. </label>
              <p><xref ref-type="bibr" rid="xp.REF.niedernhofer.2006.1038">Niedernhofer et al [2006]</xref> described a male age 15 years with cachexia, dwarfism, and microcephaly, marked sun sensitivity from birth, visual impairment due to optic atrophy, hearing loss, mild learning disabilities, progressive growth failure,facial features characteristic of premature aging, mild ataxia, and poor coordination. <xref ref-type="bibr" rid="xp.REF.niedernhofer.2006.1038">Niedernhofer et al [2006]</xref> proposed that this represented a new progeroid syndrome. Whether XFE progeroid syndrome represents a distinct condition or is part of the spectrum of XP, FA, or XP/CS has not been determined.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Sporadic tumors.</bold> Investigation of the association between an increased cancer risk and heterozygosity for an allelic variant causing XP is an active area of research.</p>
      </sec>
      <sec id="xp.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Xeroderma pigmentosum (XP), XP with neurologic abnormalities, Cockayne syndrome (CS), the XP/CS complex, trichothiodystrophy (TTD), the XP/TTD complex, cerebrooculofacioskeletal (COFS) syndrome, COFS/TTD, CS/TTD complex, and the UV-sensitive syndrome [<xref ref-type="bibr" rid="xp.REF.horibata.2004.15410">Horibata et al 2004</xref>, <xref ref-type="bibr" rid="xp.REF.berneburg.2007">Berneburg &#x00026; Kraemer 2007</xref>, <xref ref-type="bibr" rid="xp.REF.kraemer.2007.1388">Kraemer et al 2007</xref>, <xref ref-type="bibr" rid="xp.REF.stefanini.2008">Stefanini &#x00026; Kraemer 2008</xref>, <xref ref-type="bibr" rid="xp.REF.kraemer.2012">Kraemer &#x00026; Ruenger 2012</xref>, <xref ref-type="bibr" rid="xp.REF.ruenger.2012">Ruenger et al 2012</xref>] represent ten genetic diseases that exhibit cutaneous photosensitivity caused by defective nucleotide excision repair (NER). They are associated with defects in 13 different genes (see <xref ref-type="fig" rid="xp.F1">Figure 1</xref>).</p>
        <table-wrap id="xp.T.autosomal_recessive_nucleotide_exci" orientation="portrait" position="anchor">
          <label>Table 5. </label>
          <caption>
            <p>Autosomal Recessive Nucleotide Excision Repair Disorders Exhibiting Cutaneous Photosensitivity</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Phenotype&#x000a0;<sup>1</sup></th>
                <th id="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene(s)</th>
                <th id="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Clinical Features</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Cerebrooculofacioskeletal (COFS) syndrome (Pena-Shokeir syndrome, type II; OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS214150">PS214150</ext-link>)</td>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">ERCC2</italic>&#x000a0;<sup>2</sup><break/><italic toggle="yes">ERCC5</italic>&#x000a0;<sup>2</sup><break/><italic toggle="yes">ERCC6</italic>&#x000a0;<sup>3</sup></td>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Progressive neurologic disorder marked by microcephaly w/intracranial calcifications &#x00026; growth failure.<break/>Ocular findings of microcornea, cataracts, &#x00026; optic atrophy are present along w/congenital joint contractures.<break/>Photosensitivity may occur w/a concurrent cellular phenotype of UV sensitivity.</td>
              </tr>
              <tr>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="cockayne" document-type="chapter">Cockayne syndrome</related-object> (CS)</td>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">ERCC6</italic><break/><italic toggle="yes">ERCC8</italic>&#x000a0;<sup>4</sup></td>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">CS type I: Normal prenatal growth w/onset of growth &#x00026; developmental abnormalities in the first 2 years. By the time the disease has become fully manifest, height, weight, &#x00026; head circumference are far below the 5th percentile. Progressive impairment of vision, hearing,&#x00026; central &#x00026; peripheral nervous system function lead to severe disability. Death typically occurs in the 1st or 2nd decade.<break/>As in XP, cells from individuals w/CS are hypersensitive to killing by UV; however, CS cells have normal post-UV unscheduled DNA synthesis (UDS). CS cells also have delayed recovery of RNA synthesis after UV exposure, reflecting their deficiency in transcription-coupled nucleotide excision repair (TC-NER).</td>
              </tr>
              <tr>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Trichothiodystrophy (TTD; OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS601675">PS601675</ext-link>)</td>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">ERCC3</italic>&#x000a0;<sup>2</sup><break/><italic toggle="yes">ERCC2</italic>&#x000a0;<sup>2</sup><break/><italic toggle="yes">GTF2H5</italic><break/><italic toggle="yes">MPLKIP</italic>&#x000a0;<sup>5</sup><break/><italic toggle="yes">GTF2E2&#x000a0;<sup>6</sup></italic></td>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Variable phenotype including photosensitivity, ichthyosis, brittle hair w/&#x0201c;tiger tail&#x0201d; appearance under polarizing microscopy&#x000a0;<sup>7</sup>, intellectual impairment, short stature, microcephaly, dysmyelination of the brain, &#x00026; the characteristic facial features of protruding ears &#x00026; micrognathia<break/>20-fold increased risk of death before age 10 years, primarily from infections&#x000a0;<sup>8</sup><break/>Frequency of pregnancy complications &#x00026; neonatal abnormalities is increased in TTD but not in mothers w/XP who have different pathogenic variants in the same gene (<italic toggle="yes">ERCC2</italic>)&#x000a0;<sup>9</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">XP/CS complex</td>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">ERCC2&#x000a0;<sup>2</sup></italic><break/><italic toggle="yes">ERCC3</italic>&#x000a0;<sup>2</sup><break/><italic toggle="yes">ERCC4</italic>&#x000a0;<sup>2</sup><break/><italic toggle="yes">ERCC5</italic>&#x000a0;<sup>10,&#x000a0;11</sup></td>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Facial freckling &#x00026; early skin cancers typical of XP &#x00026; some features of CS (e.g., intellectual disability, spasticity, short stature, hypogonadism) but not skeletal dysplasia. In contrast to XP, in which neuronal degeneration predominates, dysmyelination typical of CS is observed in XP/CS.</td>
              </tr>
              <tr>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">COFS/TTD</td>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">ERCC2</italic>&#x000a0;<sup>12</sup></td>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Combined features of COFS &#x00026; TTD</td>
              </tr>
              <tr>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CS/TTD complex</td>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">ERCC2</italic>&#x000a0;<sup>12</sup></td>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Combined features of CS &#x00026; TTD</td>
              </tr>
              <tr>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">UV-sensitive syndrome</td>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">ERCC6</italic>&#x000a0;<sup>13</sup><break/><italic toggle="yes">ERCC8</italic>&#x000a0;<sup>13</sup><break/><italic toggle="yes">UVSSA</italic>&#x000a0;<sup>13</sup></td>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Mild photosensitivity w/out pigmentary abnormalities or apparent defects in the central nervous system. Cells from affected individuals have the same transcription defects as those in individuals w/CS.</td>
              </tr>
              <tr>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">XP/TTD complex</td>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">ERCC2</italic>&#x000a0;<sup>14</sup></td>
                <td headers="hd_h_xp.T.autosomal_recessive_nucleotide_exci_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Phenotypic features of TTD w/the clinical &#x00026; cellular phenotype of XP. Unlike most people w/TTD, those w/XP/TTD may experience increased frequency of skin cancers.</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>MOI = mode of inheritance</p>
            </fn>
            <fn>
              <p>AR = autosomal recessive</p>
            </fn>
            <fn id="xp.TF.5.1">
              <label>1. </label>
              <p>See hyperlinked <italic toggle="yes">GeneReview</italic>, OMIM phenotype entry, or cited reference for more information.</p>
            </fn>
            <fn id="xp.TF.5.2">
              <label>2. </label>
              <p>Allelic with XP</p>
            </fn>
            <fn id="xp.TF.5.3">
              <label>3. </label>
              <p><xref ref-type="bibr" rid="xp.REF.meira.2000.1221">Meira et al [2000]</xref>, <xref ref-type="bibr" rid="xp.REF.graham.2001.291">Graham et al [2001]</xref></p>
            </fn>
            <fn id="xp.TF.5.4">
              <label>4. </label>
              <p>Two individuals with Cockayne syndrome and one individual with phenotypic features of Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia had biallelic pathogenic variants in either <italic toggle="yes">ERCC1</italic> or <italic toggle="yes">ERCC4</italic> [<xref ref-type="bibr" rid="xp.REF.kashiyama.2013.807">Kashiyama et al 2013</xref>].</p>
            </fn>
            <fn id="xp.TF.5.5">
              <label>5. </label>
              <p><xref ref-type="bibr" rid="xp.REF.broughton.2001.2539">Broughton et al [2001]</xref>, <xref ref-type="bibr" rid="xp.REF.itin.2001.891">Itin et al [2001]</xref>, <xref ref-type="bibr" rid="xp.REF.bootsma.2002">Bootsma et al [2002]</xref>, <xref ref-type="bibr" rid="xp.REF.gigliamari.2004.714">Giglia-Mari et al [2004]</xref>, <xref ref-type="bibr" rid="xp.REF.liang.2005.224">Liang et al [2005]</xref>, <xref ref-type="bibr" rid="xp.REF.kraemer.2007.1388">Kraemer et al [2007]</xref>, <xref ref-type="bibr" rid="xp.REF.heller.2015.734">Heller et al [2015]</xref></p>
            </fn>
            <fn id="xp.TF.5.6">
              <label>6. </label>
              <p>
                <xref ref-type="bibr" rid="xp.REF.kuschal.2016.627">Kuschal et al [2016]</xref>
              </p>
            </fn>
            <fn id="xp.TF.5.7">
              <label>7. </label>
              <p>
                <xref ref-type="bibr" rid="xp.REF.liang.2005.224">Liang et al [2005]</xref>
              </p>
            </fn>
            <fn id="xp.TF.5.8">
              <label>8. </label>
              <p>
                <xref ref-type="bibr" rid="xp.REF.faghri.2008.609">Faghri et al [2008]</xref>
              </p>
            </fn>
            <fn id="xp.TF.5.9">
              <label>9. </label>
              <p><xref ref-type="bibr" rid="xp.REF.moslehi.2010.365">Moslehi et al [2010]</xref>, <xref ref-type="bibr" rid="xp.REF.tamura.2011.1046">Tamura et al [2011]</xref>, <xref ref-type="bibr" rid="xp.REF.tamura.2012.1308">Tamura et al [2012]</xref></p>
            </fn>
            <fn id="xp.TF.5.10">
              <label>10. </label>
              <p>See <xref ref-type="table" rid="xp.T.phenotype_correlations_by_gene_in_x">Table 2</xref> and <xref ref-type="fig" rid="xp.F1">Figure 1</xref>.</p>
            </fn>
            <fn id="xp.TF.5.11">
              <label>11. </label>
              <p>
                <xref ref-type="bibr" rid="xp.REF.kashiyama.2013.807">Kashiyama et al [2013]</xref>
              </p>
            </fn>
            <fn id="xp.TF.5.12">
              <label>12. </label>
              <p>See <xref ref-type="bibr" rid="xp.REF.digiovanna.2012.785">DiGiovanna &#x00026; Kraemer [2012]</xref></p>
            </fn>
            <fn id="xp.TF.5.13">
              <label>13. </label>
              <p><xref ref-type="bibr" rid="xp.REF.itoh.1994.233">Itoh et al [1994]</xref>, <xref ref-type="bibr" rid="xp.REF.horibata.2004.15410">Horibata et al [2004]</xref>, <xref ref-type="bibr" rid="xp.REF.nardo.2009.6209">Nardo et al [2009]</xref>, <xref ref-type="bibr" rid="xp.REF.nakazawa.2012.586">Nakazawa et al [2012]</xref>, <xref ref-type="bibr" rid="xp.REF.schwertman.2012.598">Schwertman et al [2012]</xref>, <xref ref-type="bibr" rid="xp.REF.zhang.2012.593">Zhang et al [2012]</xref>, <xref ref-type="bibr" rid="xp.REF.wilson.2016.773">Wilson et al [2016]</xref></p>
            </fn>
            <fn id="xp.TF.5.14">
              <label>14. </label>
              <p><xref ref-type="bibr" rid="xp.REF.broughton.2001.2539">Broughton et al [2001]</xref>, <xref ref-type="bibr" rid="xp.REF.boyle.2008.1194">Boyle et al [2008]</xref>, <xref ref-type="bibr" rid="xp.REF.digiovanna.2012.785">DiGiovanna &#x00026; Kraemer [2012]</xref></p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <sec id="xp.Other">
          <title>Other</title>
          <p>In addition to diseases sharing deficient nucleotide excision repair, other diseases exhibiting cutaneous photosensitivity may be considered, especially in cases with a paucity of other clinical findings. These other diseases include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><related-object link-type="booklink" source-id="gene" document-id="rts" document-type="chapter">Rothmund-Thomson syndrome</related-object> and the allelic disorder <related-object link-type="booklink" source-id="gene" document-id="bgs" document-type="chapter">Baller-Gerold syndrome</related-object></p>
            </list-item>
            <list-item>
              <p>Hartnup disorder (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/234500">234500</ext-link>), a disorder of amino acid absorption resulting from biallelic pathogenic variants in <italic toggle="yes">SLC6A19</italic>, a non-polar amino acid transporter. Affected individuals may have reduced levels of niacin with resulting pellagra-like symptoms of photosensitivity with dermatitis, diarrhea, and dementia. However, individuals with Hartnup disorder are not reported to have increased frequency of skin cancer, as is seen in those with XP.</p>
            </list-item>
          </list>
          <p>The cutaneous findings of <related-object link-type="booklink" source-id="gene" document-id="carney" document-type="chapter">Carney complex</related-object> may be confused with those of XP; however, Carney complex is characterized by lentigines without evidence of the usually associated signs of skin damage such as atrophy and telangiectasia (i.e., poikiloderma) and cutaneous findings are not limited to sun-exposed sites [<xref ref-type="bibr" rid="xp.REF.correa.2015.m85">Correa et al 2015</xref>].</p>
        </sec>
      </sec>
      <sec id="xp.Management">
        <title>Management</title>
        <sec id="xp.Evaluations_Following_Initial_Diagnos">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with xeroderma pigmentosum (XP), the following evaluations are recommended (reviewed in <xref ref-type="bibr" rid="xp.REF.tamura.2014">Tamura et al [2014]</xref>).</p>
          <p>
            <bold>Skin</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Perform baseline examination of the skin (including all sun-exposed as well as sun-shielded areas) for evidence of sunlight-induced damage including pigmentary changes, precancerous lesions, and skin cancers.</p>
            </list-item>
            <list-item>
              <p>For examination of the scalp, use a hair dryer (on a cool setting) to blow the hair aside.</p>
            </list-item>
            <list-item>
              <p>Examination of the lip and adjacent tip of the tongue for signs of sun damage, including actinic cheilitis (a type of actinic keratosis or leukoplakia occurring on the lips) and prominent telangiectasia, which may precede the development of cancer in these areas [<xref ref-type="bibr" rid="xp.REF.butt.2010.534">Butt et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>Baseline clinical color photographs of the entire skin surface with close-ups (including a ruler) of individual lesions to facilitate follow-up and detection of early skin cancers.</p>
            </list-item>
          </list>
          <p>
            <bold>Eyes</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Examine the lids and anterior UV-exposed portions of the globe for evidence of sun-induced damage including ectropion, entropion, inflammatory masses (pterygia, pinguecula), clouding of the cornea, and cancer of the lids, conjunctiva, or cornea. Eversion of the lids may be necessary to detect cancers of the mucosal surface.</p>
            </list-item>
            <list-item>
              <p>Use the Schirmer test to detect dry eyes. This test involves measurement of the extent of absorption of tears into filter paper placed under eyelids for a few minutes [<xref ref-type="bibr" rid="xp.REF.brooks.2013.1324">Brooks et al 2013</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Neurologic</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Deep tendon reflex testing</p>
            </list-item>
            <list-item>
              <p>Measurement of the occipital frontal circumference (OFC), to determine if microcephaly is present</p>
            </list-item>
            <list-item>
              <p>MRI of the brain and nerve conduction velocities, if other neurologic problems are detected</p>
            </list-item>
          </list>
          <p><bold>Auditory.</bold> Baseline audiometry evaluation to screen for the sensorineural hearing loss, which may be present as a component of the XP-associated neurologic abnormalities [<xref ref-type="bibr" rid="xp.REF.totonchy.2013.194">Totonchy et al 2013</xref>]</p>
          <p><bold>Genetic.</bold> Consultation with a clinical geneticist and/or genetic counselor</p>
        </sec>
        <sec id="xp.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The treatment of manifestations is reviewed in <xref ref-type="bibr" rid="xp.REF.tamura.b">Tamura et al [2010b]</xref> and <xref ref-type="bibr" rid="xp.REF.tamura.2014">Tamura et al [2014]</xref>.</p>
          <p><bold>Skin.</bold> Premalignant lesions (e.g., small actinic keratosis) may be treated by freezing with liquid nitrogen.</p>
          <p>Larger areas of sun-damaged skin can be treated with field treatments such as topical 5-fluorouracil or imiquimod preparations. Rarely, therapeutic dermatome shaving or dermabrasion has been used to remove the more damaged superficial epidermal layers. This procedure permits repopulation by relatively UV-shielded cells from the follicles and glands.</p>
          <p>Cutaneous neoplasms are treated in the same manner as in individuals who do not have XP. This involves electrodesiccation/curettage or surgical excision. Skin cancers which are recurrent or in locations at high risk for recurrence are best treated with Mohs micrographic surgery. Because multiple surgical procedures are often necessary, removal of undamaged skin should be minimized. Severe cases have been treated by excision of large portions of the facial surface and grafting with sun-protected skin.</p>
          <p>While individuals with XP are not abnormally sensitive to therapeutic x-rays, and individuals with XP have responded normally to full-dose therapeutic x-radiation for treatment of inoperable neoplasms [<xref ref-type="bibr" rid="xp.REF.digiovanna.1998.153">DiGiovanna et al 1998</xref>], cultured cells from a few individuals with XP were found to be hypersensitive to x-radiation [<xref ref-type="bibr" rid="xp.REF.arlett.2006.510">Arlett et al 2006</xref>]. When x-radiation therapy is indicated, an initial small dose is advisable to test for clinical hypersensitivity.</p>
          <p>Oral isotretinoin or acitretin can be effective in preventing new neoplasms in individuals with multiple skin cancers [<xref ref-type="bibr" rid="xp.REF.kraemer.1988.1633">Kraemer et al 1988</xref>]. Because of its toxicity (hepatic, hyperlipidemic, and teratogenic effects; calcification of ligaments and tendons; premature closure of the epiphyses), oral isotretinoin or acitretin should be reserved for individuals with XP who are actively developing large numbers of new tumors. Some individuals may respond to lower doses of isotretinoin or acitretin with less toxicity.</p>
          <p>A few case reports have described regression of skin cancers with use of imiquimod cream in individuals with XP [<xref ref-type="bibr" rid="xp.REF.giannotti.2003.33">Giannotti et al 2003</xref>, <xref ref-type="bibr" rid="xp.REF.nagore.2003.858">Nagore et al 2003</xref>, <xref ref-type="bibr" rid="xp.REF.roseeuw.2003.30">Roseeuw 2003</xref>]; however, no controlled studies have been reported.</p>
          <p><bold>Eyes.</bold> Methylcellulose eye drops or soft contact lenses have been used to keep the cornea moist and to protect against mechanical trauma in individuals with deformed eyelids.</p>
          <p>Corneal transplantation has restored vision in individuals with severe keratitis with corneal opacity. However, the immunosuppression necessary to prevent rejection of the transplant may increase the risk for skin cancer.</p>
          <p>Neoplasms of the lids, conjunctiva, and cornea are usually treated surgically.</p>
          <p><bold>Hearing.</bold> Hearing aids can be of great help for individuals who have sensorineural hearing loss with learning difficulties in school (see <xref ref-type="bibr" rid="xp.REF.totonchy.2013.194">Totonchy et al [2013]</xref> and <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Deafness and Hereditary Hearing Loss Overview</related-object>).</p>
        </sec>
        <sec id="xp.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <p>Treatment of XP depends on early diagnosis and immediate, aggressive avoidance of sun and other UV exposure. This involves avoiding or minimizing outdoor exposure at times when UV radiation is present (when the sun is out or during daytime through clouds).</p>
          <p>Clinical suspicion of XP should prompt immediate sun-protective measures until the diagnosis is confirmed or an alternative explanation is determined.</p>
          <p>Individuals should be educated to protect all body surfaces from UV radiation by wearing protective clothing including hats, long sleeves, long pants and gloves, broad-spectrum, high sun-protective factor (SPF) sunscreens, UV-absorbing glasses, and long hair styles. The eyes should be protected by wearing UV-absorbing glasses with side shields. Some individuals have custom-made hats with UV-absorbing face shields to permit visibility outdoors while protecting the face from UV.</p>
          <p>Because the cells of individuals with XP are hypersensitive to UVA and UVB (found in sunlight) and UVC (found in some artificial light sources), it is useful to measure UV light in an individual's home, school, or work environment with a light meter so that high levels of environmental UV (e.g., halogen lamps) can be identified and eliminated if possible. While no standards exist for perfectly safe UV exposure in individuals with XP, the use of UV meters can alert individuals to unexpected sources of high levels of environmental UV.</p>
        </sec>
        <sec id="xp.Prevention_of_Secondary_Complications">
          <title>Prevention of Secondary Complications</title>
          <p>Vitamin D is produced in the skin by a reaction involving exposure to UV radiation. Active adults with XP and skin cancers received sufficient vitamin D in their diet in the past to result in normal serum concentrations of the active form (1,25 dihydroxy vitamin D) [<xref ref-type="bibr" rid="xp.REF.sollitto.1997.942">Sollitto et al 1997</xref>]. However, children protected from sunlight very early in life have had low serum concentration of 25 hydroxy vitamin D; one child became susceptible to bone fractures [<xref ref-type="bibr" rid="xp.REF.ali.2009.442">Ali et al 2009</xref>; Author, personal observation]. Dietary supplementation with oral vitamin D is recommended for persons with low serum concentration of serum vitamin D [<xref ref-type="bibr" rid="xp.REF.reichrath.2007.664">Reichrath 2007</xref>; Author, personal communication].</p>
        </sec>
        <sec id="xp.Surveillance">
          <title>Surveillance</title>
          <p>See <xref ref-type="bibr" rid="xp.REF.tamura.b">Tamura et al [2010b]</xref> and <xref ref-type="bibr" rid="xp.REF.tamura.2014">Tamura et al [2014]</xref>.</p>
          <p><bold>Skin.</bold> A physician should examine the skin of an affected individual at frequent intervals (every ~3-12 months, depending on the severity of skin disease).</p>
          <p>Affected individuals or their parents should be educated to look for abnormal pigmented lesions or the appearance of basal cell or squamous cell carcinoma. Individuals should be examined frequently by a family member who has been instructed in recognition of cutaneous neoplasms.</p>
          <p><bold>Eyes</bold> should be examined regularly for signs of UV exposure and damage.</p>
          <p><bold>Neurologic.</bold> Routine neurologic examination is indicated because of progressive neurologic abnormalities that are present in a minority of individuals with XP and may not be detected in young children.</p>
          <p><bold>Hearing.</bold> Periodic audiograms. Serial audiograms at regular intervals may also be useful for assessing the presence or absence of progressive neurologic degeneration, especially in those with a history of acute burning on minimal sun exposure [<xref ref-type="bibr" rid="xp.REF.totonchy.2013.194">Totonchy et al 2013</xref>].</p>
        </sec>
        <sec id="xp.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>UV exposure from sunlight and artificial sources of UV radiation should be avoided (see <xref ref-type="sec" rid="xp.Prevention_of_Primary_Manifestations">Prevention of Primary Manifestations</xref>).</p>
          <p><bold>Artificial sources of UV.</bold> Certain light sources (e.g., mercury arc, halogen, and other lamps) can be unrecognized sources of UV. Although such light sources are often shielded, in open areas such as gymnasiums they can be a source of UV if the shield has been breached. UV meters are readily available to enable monitoring of areas to identify unexpected UV sources.</p>
          <p><bold>Cigarette smoke.</bold> Because cells from individuals with XP are also hypersensitive to environmental mutagens, such as benzo[<italic toggle="yes">a</italic>]pyrene found in cigarette smoke, prudence dictates that individuals with XP should be protected against these agents. One individual with XP who smoked cigarettes for more than ten years died of bronchogenic carcinoma of the lungs at age 35 years [<xref ref-type="bibr" rid="xp.REF.kraemer.1994.1018">Kraemer et al 1994</xref>]. The authors recently cared for another individual with XP who smoked and developed lung cancer in the fifth decade of life.</p>
        </sec>
        <sec id="xp.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate the apparently asymptomatic older and younger sibs of a proband in order to identify as early as possible those who would benefit from prompt initiation of treatment and preventive measures.</p>
          <list list-type="bullet">
            <list-item>
              <p>If the family-specific pathogenic variants have been identified, molecular genetic testing for at-risk sibs is possible.</p>
            </list-item>
            <list-item>
              <p>Clinical evaluation to identify affected sibs of a proband may be difficult, especially in an infant or young child. In this case, sun protection may be recommended for sibs until a definitive laboratory diagnosis is obtained.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="xp.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="xp.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>The systemic retinoids isotretinoin and acitretin are used as skin cancer chemopreventive agents in individuals who are actively developing large numbers of skin cancers, and thus may be used by some women with XP [<xref ref-type="bibr" rid="xp.REF.kraemer.1988.1633">Kraemer et al 1988</xref>]. Systemic retinoids are known to be teratogenic to a developing fetus and pose a high risk for birth defects. Therefore, women who are using systemic retinoids should be appropriately counseled about pregnancy risks and the need for effective contraception; regular monitoring with pregnancy tests is indicated. Systemic retinoids should be administered only by physicians who are knowledgeable regarding their risks and benefits.</p>
          <p>To access isotretinoin in the US, women and their prescribing providers must be enrolled in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ipledgeprogram.com/default.aspx">iPLEDGE program</ext-link> to minimize the potential for fetal exposure. Pregnancy avoidance is initiated before therapy, continues during therapy, and extends post-treatment until the drug is cleared from the body. While both drugs may be effective in preventing skin cancers, acitretin may take longer to be eliminated from the body, requiring an extended period (3 years) of post-therapy pregnancy avoidance to minimize teratogenic risk.</p>
        </sec>
        <sec id="xp.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>The bacterial DNA repair enzyme T4 endonuclease V in a topical liposome-containing preparation has been reported to reduce the frequency of new actinic keratoses and basal cell carcinomas in individuals with XP in one research study [<xref ref-type="bibr" rid="xp.REF.yarosh.2001.926">Yarosh et al 2001</xref>]. As of 2016, this treatment is not approved by the US Food and Drug Administration.</p>
          <p>Oral vismodegib (Erivedge<sup>&#x000ae;</sup>), an inhibitor of the hedgehog pathway, has been approved by the FDA for treatment of metastatic basal cell carcinoma or locally advanced basal cell carcinoma that has recurred following surgery. This drug has also been approved for use in individuals with basal cell carcinoma who are not candidates for surgery or for radiation therapy (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203388lbl.pdf">FDA package insert</ext-link>). This treatment may be appropriate for some individuals with XP, however, no studies on the efficacy of this drug in those with XP have been published. Oral vismodegib is also a teratogen, leading to embryo-fetal death, midline defects, missing digits, and other birth defects in an exposed embryo or fetus; effective contraception during and after vismodegib treatment is advised in both women and men.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
        <sec id="xp.Other_1">
          <title>Other</title>
          <p>Use of cotton swabs to obtain specimens from conjunctival lesions for cytologic examination for malignant cells is being evaluated [<xref ref-type="bibr" rid="xp.REF.brooks.2013.1324">Brooks et al 2013</xref>].</p>
        </sec>
      </sec>
      <sec id="xp.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="xp.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Xeroderma pigmentosum (XP) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="xp.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an individual with XP are obligate heterozygotes (i.e., carriers of one XP-related pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) of XP-related pathogenic variants are clinically unaffected.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are clinically unaffected.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The offspring of an individual with XP are obligate heterozygotes (carriers) for an XP-related pathogenic variant and are clinically unaffected.</p>
            </list-item>
            <list-item>
              <p>The offspring of an individual with XP and a clinically unaffected individual heterozygous for an XP-related pathogenic variant will have a 50% chance of having XP. This is a consideration in populations with a founder variant or with a high rate of consanguinity.</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier of an XP-related pathogenic variant.</p>
        </sec>
        <sec id="xp.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the XP-related pathogenic variants in the family (see <xref ref-type="bibr" rid="xp.REF.christenzaech.2009.1285">Christen-Zaech et al [2009]</xref> for discussion).</p>
          <p>Carrier testing of reproductive partners of known carriers is possible for variants in XP-related genes.</p>
        </sec>
        <sec id="xp.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="xp.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="xp.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the XP-related pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for XP are possible.</p>
        </sec>
      </sec>
      <sec id="xp.Resources">
        <title>Resources</title>
      </sec>
      <sec id="xp.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="xp.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>An intact DNA repair system that senses, excises, and repairs UV-induced dipyrimidine photoproducts and other forms of DNA damage is necessary to prevent replication errors and subsequent tumorigenesis (<xref ref-type="fig" rid="xp.F2">Figure 2</xref>) [<xref ref-type="bibr" rid="xp.REF.digiovanna.2012.785">DiGiovanna &#x00026; Kraemer 2012</xref>].</p>
          <p>Exposure to UV radiation from sunlight forms cyclobutane dimers or other photoproducts at adjacent pyrimidines, thereby distorting the DNA. Initial lesion recognition in non-transcribed DNA (global genome repair-GGR) is performed by <italic toggle="yes">DDB2</italic>-encoded protein [<xref ref-type="bibr" rid="xp.REF.clement.2010.21">Clement et al 2010</xref>, <xref ref-type="bibr" rid="xp.REF.sugasawa.2010.29">Sugasawa 2010</xref>]. The <italic toggle="yes">XPC</italic>-encoded protein binding to the photoproducts is facilitated by the binding of the <italic toggle="yes">DDB2</italic>-encoded protein. The <italic toggle="yes">XPC</italic>-encoded protein is complexed with hHR23B and centrin [<xref ref-type="bibr" rid="xp.REF.sugasawa.2010.29">Sugasawa 2010</xref>].</p>
          <p>DNA damage in transcribed genes (transcription coupled repair [TCR]) is marked by stalled RNA polymerase. The CS encoded proteins (along with others) bind to the damage in the transcribed DNA strand.</p>
          <p>In both global genome repair and transcription coupled repair the XPA protein probably functions in conjunction with replication protein A (RPA), and TFIIH. The XPB/ERCC3 and XPD/ERCC2 proteins (helicases which are part of the TFIIH complex) partially unwind the DNA in the region of the damage, thereby exposing the lesion for further processing. The XPF/ERCC4 product, in a complex with ERCC1, makes a single-strand nick at the 5' side of the lesion, while the XPG/ERCC5 product makes a similar nick on the 3' side, resulting in the release of a region of approximately 30 nucleotides containing the damage. The resulting gap is filled by DNA polymerase using the other (undamaged) strand as a template in a process involving proliferating cell nuclear antigen. DNA ligase I seals the region, restoring the original undamaged sequence [<xref ref-type="bibr" rid="xp.REF.van_steeg.1999.86">van Steeg &#x00026; Kraemer 1999</xref>, <xref ref-type="bibr" rid="xp.REF.bootsma.2002">Bootsma et al 2002</xref>].</p>
          <p>The nucleotide excision repair genes (e.g., XPB/<italic toggle="yes">ERCC3</italic> and XPD/<italic toggle="yes">ERCC2</italic>) that are part of the basal transcription factor TFIIH are essential to life. Mice with knockout of <italic toggle="yes">Ercc2</italic> do not survive, whereas <italic toggle="yes">Xpa</italic> and <italic toggle="yes">Xpc</italic> knockout mice are viable.</p>
          <p>For detailed summary of gene and protein information for the genes listed below, see <related-object source-id="gene" document-id="xp" object-id="xp.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <sec id="xp.DDB2_XPE">
            <title><italic toggle="yes">DDB2</italic> (<italic toggle="yes">XPE</italic>)</title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">DDB2</italic> codes for a 1.8-kb RNA. It comprises ten exons and nine introns (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000107.2">NM_000107.2</ext-link>).</p>
            <p><bold>Pathogenic variants.</bold> Missense, nonsense, and frameshift variants have been reported [<xref ref-type="bibr" rid="xp.REF.nichols.1996.24317">Nichols et al 1996</xref>, <xref ref-type="bibr" rid="xp.REF.rapi_otrin.2003.1507">Rapi&#x00107;-Otrin et al 2003</xref>, <xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>] (see also <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v22/n7/full/ejhg2013233a.html">Clinical Utility Gene Card</ext-link>).</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">DDB2</italic> codes for a 48-kd protein of 427 amino acids. <italic toggle="yes">DDB2</italic> combined with <italic toggle="yes">DDB1</italic> forms a heterodimer, which, along with <italic toggle="yes">XPC</italic>, is involved in the initial recognition of UV-induced DNA damage in non-transcribed portions of the genome.</p>
            <p><bold>Abnormal gene product.</bold> XP results from absent or <related-object source-id="gene" document-id="xp" object-id="xp.molgen.TA">inactivated DNA damage-binding protein 2</related-object>. Loss of the p48 subunit encoded by <italic toggle="yes">DDB2</italic> results in large numbers of skin cancers without acute burning on minimal sun exposure [<xref ref-type="bibr" rid="xp.REF.oh.2011.785">Oh et al 2011</xref>, <xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>]. See also <xref ref-type="table" rid="xp.T.phenotype_correlations_by_gene_in_x">Table 2</xref>.</p>
          </sec>
          <sec id="xp.ERCC1">
            <title>
              <italic toggle="yes">ERCC1</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">ERCC1</italic> codes for a 1.2-kb mRNA. It comprises eight exons (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001983.3">NM_001983.3</ext-link>).</p>
            <p><bold>Pathogenic variants.</bold> One individual with COFS syndrome was reported by <xref ref-type="bibr" rid="xp.REF.jaspers.2007.457">Jaspers et al [2007]</xref>. One individual with severe CS was compound heterozygous for two pathogenic variants, p.Lys226Ter and p.Phe231Leu, in <italic toggle="yes">ERCC1</italic> [<xref ref-type="bibr" rid="xp.REF.kashiyama.2013.807">Kashiyama et al 2013</xref>] (see also <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v22/n7/full/ejhg2013233a.html">Clinical Utility Gene Card</ext-link>).</p>
            <table-wrap id="xp.T.ercc1_variants_discussed_in_this_ge" orientation="portrait" position="anchor">
              <label>Table 6. </label>
              <caption>
                <p><italic toggle="yes">ERCC1</italic> Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_xp.T.ercc1_variants_discussed_in_this_ge_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_xp.T.ercc1_variants_discussed_in_this_ge_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_xp.T.ercc1_variants_discussed_in_this_ge_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_xp.T.ercc1_variants_discussed_in_this_ge_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.676A&#x0003e;T</td>
                    <td headers="hd_h_xp.T.ercc1_variants_discussed_in_this_ge_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Lys226Ter</td>
                    <td headers="hd_h_xp.T.ercc1_variants_discussed_in_this_ge_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_202001.2">NM_202001.2</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_973730.1">NP_973730.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_xp.T.ercc1_variants_discussed_in_this_ge_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.693C&#x0003e;G</td>
                    <td headers="hd_h_xp.T.ercc1_variants_discussed_in_this_ge_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe231Leu</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">ERCC1</italic> codes for a 110-kd protein of 323 amino acids.</p>
            <p><bold>Abnormal gene product.</bold> XP results from absent or inactivated DNA excision repair protein ERCC-1.</p>
          </sec>
          <sec id="xp.ERCC2_XPD">
            <title><italic toggle="yes">ERCC2</italic> (<italic toggle="yes">XPD</italic>)</title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">ERCC2</italic> codes for a 2.3-kb mRNA. It comprises 22 exons and 21 introns (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000400.3">NM_000400.3</ext-link>).</p>
            <p><bold>Pathogenic variants.</bold> Individuals with pathogenic variants in <italic toggle="yes">ERCC2</italic> exhibit significant allelic heterogeneity. Missense variants with resulting change in amino acids with some residual activity [<xref ref-type="bibr" rid="xp.REF.lehmann.2001.15">Lehmann 2001</xref>] are frequently found in cells from individuals with XP-D [<xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>]. The p.Arg683Trp pathogenic variant is common in the Iraqi Jewish population [<xref ref-type="bibr" rid="xp.REF.falikzaccai.2012.505">Falik-Zaccai et al 2012</xref>] and occurs at a hot spot. The p.Arg683Gln pathogenic variant has been reported in individuals with XP in many parts of the world [<xref ref-type="bibr" rid="xp.REF.taylor.1997.8658">Taylor et al 1997</xref>, <xref ref-type="bibr" rid="xp.REF.boyle.2008.1194">Boyle et al 2008</xref>] (see also <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v22/n7/full/ejhg2013233a.html">Clinical Utility Gene Card</ext-link>).</p>
            <p>Individuals with pathogenic variants in <italic toggle="yes">ERCC2</italic> may have an XP, TTD, or XP/TTD phenotype [<xref ref-type="bibr" rid="xp.REF.zhou.2013.831">Zhou et al 2013</xref>].</p>
            <p>A mild phenotype was reported in Israel [<xref ref-type="bibr" rid="xp.REF.falikzaccai.2012.505">Falik-Zaccai et al 2012</xref>].</p>
            <table-wrap id="xp.T.ercc2_variants_discussed_in_this_ge" orientation="portrait" position="anchor">
              <label>Table 7. </label>
              <caption>
                <p><italic toggle="yes">ERCC2</italic> Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_xp.T.ercc2_variants_discussed_in_this_ge_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_xp.T.ercc2_variants_discussed_in_this_ge_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_xp.T.ercc2_variants_discussed_in_this_ge_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_xp.T.ercc2_variants_discussed_in_this_ge_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2047C&#x0003e;T</td>
                    <td headers="hd_h_xp.T.ercc2_variants_discussed_in_this_ge_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg683Trp</td>
                    <td headers="hd_h_xp.T.ercc2_variants_discussed_in_this_ge_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000400.3">NM_000400.3</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000391.1">NP_000391.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_xp.T.ercc2_variants_discussed_in_this_ge_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2048G&#x0003e;A</td>
                    <td headers="hd_h_xp.T.ercc2_variants_discussed_in_this_ge_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg683Gln</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">ERCC2</italic> codes for an 86.9-kd protein of 760 amino acids. ERCC2, like the ERCC3 (XPB) protein, is also a DNA helicase (but unwinds DNA in the 5'- 3' direction). ERCC2 is part of basal transcription factor TFIIH that is involved in regulation of the basal rate of transcription (RNA synthesis) of active genes, as well as in NER.</p>
            <p><bold>Abnormal gene product.</bold> XP results from absent or<related-object source-id="gene" document-id="xp" object-id="xp.molgen.TA"> inactivated TFIIH basal transcription factor complex helicase XPD subunit</related-object>. Abnormal ERCC2 in persons with XP results in persistent NER protein accumulation at sites of DNA damage while abnormal ERCC2 in persons with TTD results in failure of accumulation of NER proteins at sites of localized DNA damage [<xref ref-type="bibr" rid="xp.REF.boyle.2008.1194">Boyle et al 2008</xref>]. See also <xref ref-type="table" rid="xp.T.phenotype_correlations_by_gene_in_x">Table 2</xref>.</p>
          </sec>
          <sec id="xp.ERCC3_XPB">
            <title><italic toggle="yes">ERCC3</italic> (<italic toggle="yes">XPB</italic>)</title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">ERCC3</italic> codes for a 2.75-kb mRNA. It comprises 15 exons and 14 introns (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000122.1">NM_000122.1</ext-link>).</p>
            <p><bold>Pathogenic variants.</bold> Nonsense, frameshift, and splicing defects have been reported [<xref ref-type="bibr" rid="xp.REF.oh.2006.1092">Oh et al 2006</xref>, <xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>] (see also <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v22/n7/full/ejhg2013233a.html">Clinical Utility Gene Card</ext-link>).</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">ERCC3</italic> codes for an 89.3-kd protein of 782 amino acids that functions as a 3'- 5' DNA helicase in unwinding DNA. The <italic toggle="yes">ERCC3</italic>-encoded protein is part of the TFIIH complex, which is involved in regulation of the basal rate of transcription (RNA synthesis) of active genes, as well as in nucleotide excision repair.</p>
            <p><bold>Abnormal gene product.</bold> XP results from absent or inactivated <related-object source-id="gene" document-id="xp" object-id="xp.molgen.TA">TFIIH basal transcription factor complex helicase XPB subunit</related-object> protein. Affected individuals have severe disease with neurologic involvement or mild disease without neurologic involvement [<xref ref-type="bibr" rid="xp.REF.oh.2007.1359">Oh et al 2007</xref>, <xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>]. See also <xref ref-type="table" rid="xp.T.phenotype_correlations_by_gene_in_x">Table 2</xref>.</p>
          </sec>
          <sec id="xp.ERCC4_XPF">
            <title><italic toggle="yes">ERCC4</italic> (<italic toggle="yes">XPF</italic>)</title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">ERCC4</italic> codes for a 6.7-kb mRNA. It comprises 11 exons and ten introns (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_005236.2">NM_005236.2</ext-link>).</p>
            <p><bold>Pathogenic variants.</bold> Missense variants have been reported [<xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>] (see also <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v22/n7/full/ejhg2013233a.html">Clinical Utility Gene Card</ext-link>).</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">ERCC4</italic> codes for a 103.3-kd protein of 905 amino acids that serves as a DNA endonuclease 5' to the lesion.</p>
            <p><bold>Abnormal gene product.</bold> XP results from absent or inactivated <related-object source-id="gene" document-id="xp" object-id="xp.molgen.TA">DNA repair endonuclease XPF</related-object>. Loss of XPF may result in mild disease or adult onset of severe neurologic degeneration [Author, personal observation], or features of FA, CS, XP/CS complex, and XP/CS/FA. See also <xref ref-type="table" rid="xp.T.phenotype_correlations_by_gene_in_x">Table 2</xref> [<xref ref-type="bibr" rid="xp.REF.bogliolo.2013.800">Bogliolo et al 2013</xref>, <xref ref-type="bibr" rid="xp.REF.kashiyama.2013.807">Kashiyama et al 2013</xref>, <xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>].</p>
          </sec>
          <sec id="xp.ERCC5_XPG">
            <title><italic toggle="yes">ERCC5</italic> (<italic toggle="yes">XPG</italic>)</title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">ERCC5</italic> codes for a 4.1-kb mRNA (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000123.3">NM_000123.3</ext-link>). It comprises 15 exons and 14 introns [<xref ref-type="bibr" rid="xp.REF.emmert.2001.1443">Emmert et al 2001</xref>].</p>
            <p><bold>Pathogenic variants.</bold> Missense, nonsense, frameshift, and splicing variants have been reported [<xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>] (see also <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v22/n7/full/ejhg2013233a.html">Clinical Utility Gene Card</ext-link>).</p>
            <p>One individual with biallelic pathogenic variants in <italic toggle="yes">ERCC5</italic> (<italic toggle="yes">XPG</italic>) and minimal neurologic involvement developed retinal atrophy and basal ganglia calcification of the XP/CS complex while being followed at the NIH [<xref ref-type="bibr" rid="xp.REF.brooks.2013.1324">Brooks et al 2013</xref>].</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">ERCC5</italic> codes for a protein of 112 kd that functions as a DNA endonuclease 3' to the lesion.</p>
            <p><bold>Abnormal gene product.</bold> XP results from absent or inactivated <related-object source-id="gene" document-id="xp" object-id="xp.molgen.TA">DNA repair protein complementing XP-G cells</related-object>. Pathogenic variants resulting in markedly truncated ERCC5 are found in individuals with XP-G with the XP/CS complex, while individuals with XP-G without neurologic disease have missense variants that retain some activity [<xref ref-type="bibr" rid="xp.REF.emmert.2002.972">Emmert et al 2002</xref>, <xref ref-type="bibr" rid="xp.REF.moriwaki.2012.304">Moriwaki et al 2012</xref>, <xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>].</p>
          </sec>
          <sec id="xp.POLH_XPV">
            <title><italic toggle="yes">POLH</italic> (<italic toggle="yes">XP-V</italic>)</title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">POLH</italic> codes for a 8.4-kb mRNA (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_006502.2">NM_006502.2</ext-link>). It comprises 11 exons and ten introns.</p>
            <p><bold>Pathogenic variants.</bold> Missense, nonsense, and frameshift variants have been described [<xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>] (see also <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v22/n7/full/ejhg2013233a.html">Clinical Utility Gene Card</ext-link>).</p>
            <p>Affected Japanese individuals were described by <xref ref-type="bibr" rid="xp.REF.tanioka.2007.1745">Tanioka et al [2007]</xref>. Affected individuals from different countries who had multiple skin cancers but no neurologic involvement were identified with pathogenic variants in <italic toggle="yes">POLH</italic> [<xref ref-type="bibr" rid="xp.REF.inui.2008.2055">Inui et al 2008</xref>]. See also <xref ref-type="table" rid="xp.T.phenotype_correlations_by_gene_in_x">Table 2</xref>.</p>
            <table-wrap id="xp.T.polh_variants_discussed_in_this_gen" orientation="portrait" position="anchor">
              <label>Table 8. </label>
              <caption>
                <p><italic toggle="yes">POLH</italic> Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_xp.T.polh_variants_discussed_in_this_gen_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_xp.T.polh_variants_discussed_in_this_gen_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_xp.T.polh_variants_discussed_in_this_gen_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_xp.T.polh_variants_discussed_in_this_gen_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.490G&#x0003e;T&#x000a0;<sup>1</sup></td>
                    <td headers="hd_h_xp.T.polh_variants_discussed_in_this_gen_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_xp.T.polh_variants_discussed_in_this_gen_1_1_1_3" rowspan="6" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_006502.2">NM_006502.2</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_006493.1">NP_006493.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_xp.T.polh_variants_discussed_in_this_gen_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.725C&#x0003e;G</td>
                    <td headers="hd_h_xp.T.polh_variants_discussed_in_this_gen_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser242Ter</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_xp.T.polh_variants_discussed_in_this_gen_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">c.764+1G&#x0003e;A</td>
                    <td headers="hd_h_xp.T.polh_variants_discussed_in_this_gen_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td headers="hd_h_xp.T.polh_variants_discussed_in_this_gen_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.916G&#x0003e;T</td>
                    <td headers="hd_h_xp.T.polh_variants_discussed_in_this_gen_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu306Ter</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_xp.T.polh_variants_discussed_in_this_gen_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">c.1661delA</td>
                    <td headers="hd_h_xp.T.polh_variants_discussed_in_this_gen_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td headers="hd_h_xp.T.polh_variants_discussed_in_this_gen_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Del exon 10</td>
                    <td headers="hd_h_xp.T.polh_variants_discussed_in_this_gen_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="xp.TF.8.1">
                  <label>1. </label>
                  <p>Results in abnormal splicing [<xref ref-type="bibr" rid="xp.REF.masaki.2008.144">Masaki et al 2008</xref>]</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">POLH</italic> (polymerase eta) codes for a 78.4-kd protein of 713 amino acids that functions as an error-prone polymerase [<xref ref-type="bibr" rid="xp.REF.broughton.2002.815">Broughton et al 2002</xref>].</p>
            <p><bold>Abnormal gene product.</bold> XP results from absent or inactivated DNA polymerase eta.</p>
          </sec>
          <sec id="xp.XPA">
            <title>
              <italic toggle="yes">XPA</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">XPA</italic> codes for a 1.4-kb mRNA. It comprises six exons and five introns (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000380.3">NM_000380.3</ext-link>).</p>
            <p><bold>Pathogenic variants.</bold> A pathogenic founder allele creating a splicing variant in exon 3 of <italic toggle="yes">XPA</italic>, c.390-1G&#x0003e;C, is estimated to occur at a carrier frequency of approximately 1% of the Japanese population. Individuals who are homozygous for this allele have severe, progressive neurologic degeneration; carriers are clinically normal [<xref ref-type="bibr" rid="xp.REF.nishigori.1994.191">Nishigori et al 1994</xref>, <xref ref-type="bibr" rid="xp.REF.hirai.2006.171">Hirai et al 2006</xref>]. This founder variant appeared in the Japanese population approximately 120 generations (~2400 years) ago [<xref ref-type="bibr" rid="xp.REF.imoto.2013.175">Imoto et al 2013</xref>]. Persons of Japanese heritage who are compound heterozygotes for this <italic toggle="yes">XPA</italic> variant and a second <italic toggle="yes">XPA</italic> variant have milder disease than those who are homozygous for the founder variant [<xref ref-type="bibr" rid="xp.REF.takahashi.2010.2481">Takahashi et al 2010</xref>] (see also <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v22/n7/full/ejhg2013233a.html">Clinical Utility Gene Card</ext-link>).</p>
            <p>A nonsense variant, p.Arg228Ter, is common in the Tunisian population and results in mild disease [<xref ref-type="bibr" rid="xp.REF.messaoud.2010.883">Messaoud et al 2010</xref>].</p>
            <p>Although other common pathogenic alleles have been described in population isolates, most pathogenic alleles are private. Nonsense variants have been reported in both alleles in cells from individuals in complementation group XP-A.</p>
            <p>Mild clinical features were found in an individual with an <italic toggle="yes">XPA</italic> splicing variant resulting in 5% of normal residual mRNA [<xref ref-type="bibr" rid="xp.REF.sidwell.2006.81">Sidwell et al 2006</xref>]. Variants near the C-terminal coding region of <italic toggle="yes">XPA</italic> had milder neurologic and cutaneous symptoms and greater residual DNA repair activity in several Japanese persons with XP [<xref ref-type="bibr" rid="xp.REF.takahashi.2010.2481">Takahashi et al 2010</xref>].</p>
            <table-wrap id="xp.T.xpa_variants_discussed_in_this_gene" orientation="portrait" position="anchor">
              <label>Table 9. </label>
              <caption>
                <p><italic toggle="yes">XPA</italic> Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_xp.T.xpa_variants_discussed_in_this_gene_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_xp.T.xpa_variants_discussed_in_this_gene_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_xp.T.xpa_variants_discussed_in_this_gene_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_xp.T.xpa_variants_discussed_in_this_gene_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.335_338delTTATinsCATAAGAAA</td>
                    <td headers="hd_h_xp.T.xpa_variants_discussed_in_this_gene_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe112SerfsTer2</td>
                    <td headers="hd_h_xp.T.xpa_variants_discussed_in_this_gene_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000380.3">NM_000380.3</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000371.1">NP_000371.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_xp.T.xpa_variants_discussed_in_this_gene_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">c.390-1G&#x0003e;C</td>
                    <td headers="hd_h_xp.T.xpa_variants_discussed_in_this_gene_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td headers="hd_h_xp.T.xpa_variants_discussed_in_this_gene_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.682C&#x0003e;T</td>
                    <td headers="hd_h_xp.T.xpa_variants_discussed_in_this_gene_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg228Ter</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">XPA</italic> codes for an mRNA corresponding to a 31.3-kd protein of 273 amino acids that functions in maintaining single-stranded regions during repair.</p>
            <p><bold>Abnormal gene product.</bold> XP results from absent or inactivated <related-object source-id="gene" document-id="xp" object-id="xp.molgen.TA">XPA protein</related-object>.</p>
          </sec>
          <sec id="xp.XPC">
            <title>
              <italic toggle="yes">XPC</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">XPC</italic> codes for a 3.5-kb mRNA (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004628.4">NM_004628.4</ext-link>). It comprises 16 exons [<xref ref-type="bibr" rid="xp.REF.khan.2002.3624">Khan et al 2002</xref>].</p>
            <p><bold>Pathogenic variants.</bold> Nonsense, splice site, and frameshift variants have been reported in both alleles in cells from individuals in complementation group XP-C. Pathogenic missense variants are less frequent [<xref ref-type="bibr" rid="xp.REF.khan.2006.84">Khan et al 2006</xref>, <xref ref-type="bibr" rid="xp.REF.fassihi.2016.e1236">Fassihi et al 2016</xref>] (see also <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v22/n7/full/ejhg2013233a.html">Clinical Utility Gene Card</ext-link>).</p>
            <p>p.Val548AlafsTer25, a founder variant in <italic toggle="yes">XPC</italic> resulting in severe disease, was reported in persons with XP from North Africa (Algeria, Morocco, and Tunisia) [<xref ref-type="bibr" rid="xp.REF.mahindra.2008.881">Mahindra et al 2008</xref>, <xref ref-type="bibr" rid="xp.REF.ben_rekaya.2009.426">Ben Rekaya et al 2009</xref>, <xref ref-type="bibr" rid="xp.REF.soufir.2010.1537">Soufir et al 2010</xref>, <xref ref-type="bibr" rid="xp.REF.tamura.2010a.1491">Tamura et al 2010a</xref>]. Haplotype analysis suggested that this variant arose about 50 generations (1250 years) ago [<xref ref-type="bibr" rid="xp.REF.soufir.2010.1537">Soufir et al 2010</xref>]. The frequency of the African <italic toggle="yes">XPC</italic> founder variant is not known.</p>
            <table-wrap id="xp.T.xpc_variants_discussed_in_this_gene" orientation="portrait" position="anchor">
              <label>Table 10. </label>
              <caption>
                <p><italic toggle="yes">XPC</italic> Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_xp.T.xpc_variants_discussed_in_this_gene_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_xp.T.xpc_variants_discussed_in_this_gene_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_xp.T.xpc_variants_discussed_in_this_gene_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_xp.T.xpc_variants_discussed_in_this_gene_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1643_1644delTG</td>
                    <td headers="hd_h_xp.T.xpc_variants_discussed_in_this_gene_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val548AlafsTer25</td>
                    <td headers="hd_h_xp.T.xpc_variants_discussed_in_this_gene_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004628.4">NM_004628.4</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_004619.3">NP_004619.3</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">XPC</italic> codes for a 105.9-kd protein of 940 amino acids. The XPC protein is involved with recognition of DNA damage and global genome repair.</p>
            <p><bold>Abnormal gene product.</bold> XP results from absent or inactivated <related-object source-id="gene" document-id="xp" object-id="xp.molgen.TA">XPC protein</related-object>. Individuals with <italic toggle="yes">XPC</italic> splice lariat variants may have severe or mild disease [<xref ref-type="bibr" rid="xp.REF.khan.2004.343">Khan et al 2004</xref>, <xref ref-type="bibr" rid="xp.REF.khan.2009.114">Khan et al 2009</xref>]: those with mild disease have about 3% of normal residual <italic toggle="yes">XPC</italic> mRNA while those with severe disease have no detectible <italic toggle="yes">XPC</italic> mRNA. Persons with pathogenic variants in <italic toggle="yes">XPC</italic> typically do not have acute burning on minimal sun exposure [<xref ref-type="bibr" rid="xp.REF.khan.2009.114">Khan et al 2009</xref>]. See also <xref ref-type="table" rid="xp.T.phenotype_correlations_by_gene_in_x">Table 2</xref>.</p>
          </sec>
        </sec>
      </sec>
      <sec id="xp.References">
        <title>References</title>
        <sec id="xp.Published_GuidelinesConsensus_Stateme">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="xp.Published_GuidelinesConsensus_Stateme.reflist0">
            <ref id="xp.REF.tamura.2010">
              <mixed-citation publication-type="book">Tamura D, DiGiovanna JJ, Kraemer KH. Xeroderma pigmentosum. In: Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I, eds. <italic toggle="yes">Treatment of Skin Disease.</italic> 3 ed. London, UK: Elsevier; 2010:789-92.</mixed-citation>
            </ref>
            <ref id="xp.REF.tamura.2014">
              <mixed-citation publication-type="book">Tamura D, Kraemer KH, DiGiovanna JJ. Xeroderma pigmentosum. In: Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I, eds. <italic toggle="yes">Treatment of Skin Disease: Comprehensive Therapeutic Strategies</italic>. 4 ed. London, UK: Elsevier; 2014.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="xp.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="xp.Literature_Cited.reflist0">
            <ref id="xp.REF.ahmad.2010.e1000871">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ahmad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enzlin</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhagwat</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijgers</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raams</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appledoorn</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theil</surname>
                    <given-names>AF</given-names>
                  </name>
                </person-group>
                <article-title>J Hoeijmakers JH, Vermeulen W, J Jaspers NG, Sch&#x000e4;rer OD, Niedernhofer LJ. Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.</article-title>
                <source>PLoS Genet.</source>
                <year>2010</year>
                <volume>6</volume>
                <fpage>e1000871</fpage>
                <pub-id pub-id-type="pmid">20221251</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.ali.2009.442">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ali</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukasa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coulson</surname>
                    <given-names>IH</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Xeroderma pigmentosum: early diagnostic features and an adverse consequence of photoprotection.</article-title>
                <source>Clin Exp Dermatol.</source>
                <volume>34</volume>
                <fpage>442</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">19309384</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.arlett.2006.510">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arlett</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plowman</surname>
                    <given-names>PN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parris</surname>
                    <given-names>CN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbaszadeh</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMillan</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bush</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foray</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Clinical and cellular ionizing radiation sensitivity in a patient with xeroderma pigmentosum.</article-title>
                <source>Br J Radiol</source>
                <volume>79</volume>
                <fpage>510</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16714754</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.ben_rekaya.2014">
              <mixed-citation publication-type="other">Ben Rekaya M, Laroussi N, Messaoud O, Jones M, Jerbi M, Naouali C, Bouyacoub Y, Chargui M, Kefi R, Fazaa B, Boubaker MS, Boussen H, Mokni M, Abdelhak S, Zghal M, Khaled A, Yacoub-Youssef H. A founder large deletion mutation in Xeroderma pigmentosum-Variant form in Tunisia: implication for molecular diagnosis and therapy. Biomed Res Int. 2014;2014:256245.</mixed-citation>
            </ref>
            <ref id="xp.REF.ben_rekaya.2009.426">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ben Rekaya</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messaoud</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talmoudi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nouira</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ouragini</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amouri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boussen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boubaker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mokni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mokthar</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdelhak</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zghal</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>High frequency of the V548A fs X572 XPC mutation in Tunisia: implication for molecular diagnosis.</article-title>
                <source>J Hum Genet.</source>
                <volume>54</volume>
                <fpage>426</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19478817</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.berneburg.2007">
              <mixed-citation publication-type="book">Berneburg M, Kraemer KH. Xeroderma pigmentosum and other DNA repair-deficient photodermatoses. In: Lim H, H&#x000f6;nigsmann H, Hawk JLM, eds. <italic toggle="yes">Photodermatology</italic>. New York, NY: Informa Healthcare; 2007:239-50.</mixed-citation>
            </ref>
            <ref id="xp.REF.bogliolo.2013.800">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bogliolo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuster</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoepker</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Derkunt</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Su</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raams</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trujillo</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minguill&#x000f3;n</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ram&#x000ed;rez</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pujol</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casado</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ba&#x000f1;os</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rio</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knies</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Z&#x000fa;&#x000f1;iga</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben&#x000ed;tez</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bueren</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000e4;rer</surname>
                    <given-names>OD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Winter</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surrall&#x000e9;s</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia.</article-title>
                <source>Am J Hum Genet</source>
                <volume>92</volume>
                <fpage>800</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23623386</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.bootsma.2002">
              <mixed-citation publication-type="book">Bootsma D, Kraemer KH, Cleaver JE, Hoeijmakers JHJ. Nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. In: Vogelstein B, Kinzler KW, eds. <italic toggle="yes">The Genetic Basis of Human Cancer</italic>. 2 ed. New York, NY: McGraw-Hill; 2002:211-37.</mixed-citation>
            </ref>
            <ref id="xp.REF.boyle.2008.1194">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boyle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jagdeo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nadem</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy.</article-title>
                <source>Hum Mutat.</source>
                <volume>29</volume>
                <fpage>1194</fpage>
                <lpage>208</lpage>
                <pub-id pub-id-type="pmid">18470933</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.bradford.2011.168">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bradford</surname>
                    <given-names>PT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldstein</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inui</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moriwaki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emmert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pike</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raziuddin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plona</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucker</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.</article-title>
                <source>J Med Genet.</source>
                <volume>48</volume>
                <fpage>168</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">21097776</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.brooks.2013.1324">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bishop</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clayton</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsilou</surname>
                    <given-names>ET</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zein</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inui</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moriwaki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emmert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iliff</surname>
                    <given-names>NT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradford</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage.</article-title>
                <source>Ophthalmology.</source>
                <year>2013</year>
                <volume>120</volume>
                <fpage>1324</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">23601806</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.broughton.2001.2539">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Broughton</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berneburg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fawcett</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arlett</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menefee</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Price</surname>
                    <given-names>VH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Queille</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarasin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohnert</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krutmann</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davidson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene.</article-title>
                <source>Hum Mol Genet</source>
                <volume>10</volume>
                <fpage>2539</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">11709541</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.broughton.2002.815">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Broughton</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cordonnier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleijer</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fawcett</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raams</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garritsen</surname>
                    <given-names>VH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stary</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avril</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boudsocq</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masutani</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanaoka</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuchs</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarasin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients.</article-title>
                <source>Proc Natl Acad Sci USA</source>
                <volume>99</volume>
                <fpage>815</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">11773631</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.butt.2010.534">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Butt</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moshi</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owibingire</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chindia</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Xeroderma pigmentosum: a review and case series.</article-title>
                <source>J Craniomaxillofac Surg.</source>
                <volume>38</volume>
                <fpage>534</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20346687</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.calmels.2016.26">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Calmels</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greff</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Obringer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kempf</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasnier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tarabeux</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miguet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baujat</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bessis</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bretones</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digeon</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doco-Fenzy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doray</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feillet</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardeazabal</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gener</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julia</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Llano-Rivas</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazur</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renaldo-Robin</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabouraud</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keren</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Depienne</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laugel</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>Uncommon nucleotide excision repair phenotypes revealed by targeted high-throughput sequencing.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2016</year>
                <volume>11</volume>
                <fpage>26</fpage>
                <pub-id pub-id-type="pmid">27004399</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.chavanne.2000.1974">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chavanne</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broughton</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietra</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Browitt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels.</article-title>
                <source>Cancer Res.</source>
                <year>2000</year>
                <volume>60</volume>
                <fpage>1974</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">10766188</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.christenzaech.2009.1285">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Christen-Zaech</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patronas</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paller</surname>
                    <given-names>AS</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Unexpected occurrence of xeroderma pigmentosum in an uncle and nephew.</article-title>
                <source>Arch Dermatol.</source>
                <volume>145</volume>
                <fpage>1285</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">19917958</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.cleaver.1999.9">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cleaver</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richardson</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>States</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy.</article-title>
                <source>Hum Mutat</source>
                <volume>14</volume>
                <fpage>9</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">10447254</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.clement.2010.21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clement</surname>
                    <given-names>FC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camenisch</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fei</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaczmarek</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathieu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naegeli</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Dynamic two-stage mechanism of versatile DNA damage recognition by xeroderma pigmentosum group C protein.</article-title>
                <source>Mutat Res.</source>
                <volume>685</volume>
                <fpage>21</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19686765</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.correa.2015.m85">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Correa</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salpea</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>Carney complex: an update.</article-title>
                <source>Eur J Endocrinol.</source>
                <year>2015</year>
                <volume>173</volume>
                <fpage>M85</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">26130139</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.digiovanna.2012.785">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Shining a light on xeroderma pigmentosum.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2012</year>
                <volume>132</volume>
                <fpage>785</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">22217736</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.digiovanna.1998.153">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patronas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abangan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Xeroderma pigmentosum: spinal cord astrocytoma with 9-year survival after radiation and isotretinoin therapy.</article-title>
                <source>J Cutan Med Surg</source>
                <volume>2</volume>
                <fpage>153</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9479081</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.dollfus.2003.107">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dollfus</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porto</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caussade</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speeg-Schatz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grosshans</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flament</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarasin</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Ocular manifestations in the inherited DNA repair disorders.</article-title>
                <source>Surv Ophthalmol.</source>
                <volume>48</volume>
                <fpage>107</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">12559331</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.emmert.2001.1443">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Emmert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The human XPG gene: gene architecture, alternative splicing and single nucleotide polymorphisms.</article-title>
                <source>Nucleic Acids Res</source>
                <volume>29</volume>
                <fpage>1443</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">11266544</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.emmert.2002.972">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Emmert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slor</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Busch</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batko</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albert</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coleman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abu-Libdeh</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cunningham</surname>
                    <given-names>BB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crollick</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inui</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedayati</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grossman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shahlavi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cleaver</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients.</article-title>
                <source>J Invest Dermatol</source>
                <volume>118</volume>
                <fpage>972</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">12060391</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.faghri.2008.609">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Faghri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations.</article-title>
                <source>J Med Genet.</source>
                <volume>45</volume>
                <fpage>609</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">18603627</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.falikzaccai.2012.505">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Falik-Zaccai</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erel-Segal</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horev</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bitterman-Deutsch</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaim</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keren</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalfon</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gross</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Segal</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orgal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoval</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slor</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spivak</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanawalt</surname>
                    <given-names>PC</given-names>
                  </name>
                </person-group>
                <article-title>A novel XPD mutation in a compound heterozygote; the mutation in the second allele is present in three homozygous patients with mild sun sensitivity.</article-title>
                <source>Environ.Mol.Mutagen.</source>
                <year>2012</year>
                <volume>53</volume>
                <fpage>505</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">22826098</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.fassihi.2016.e1236">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fassihi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sethi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fawcett</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wing</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chandler</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohammed</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craythorne</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morley</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henshaw</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garrood</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giunti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedderly</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abiona</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naik</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harrop</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGibbon</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Botta</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarkany</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <article-title>Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2016</year>
                <volume>113</volume>
                <fpage>E1236</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">26884178</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.giannotti.2003.33">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giannotti</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanzi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Difonzo</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pimpinelli</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The treatment of basal cell carcinomas in a patient with xeroderma pigmentosum with a combination of imiquimod 5% cream and oral acitretin.</article-title>
                <source>Clin Exp Dermatol.</source>
                <volume>28</volume>
                <supplement>Suppl 1</supplement>
                <fpage>33</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">14616811</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.gigliamari.2004.714">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giglia-Mari</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coin</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ranish</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoogstraten</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theil</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijgers</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raams</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Argentini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van der Spek</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Botta</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Egly</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aebersold</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoeijmakers</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeulen</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A new, tenth subunit of TFIIH is responsible for the DNA repair syndrome trichothiodystrophy group A.</article-title>
                <source>Nat Genet</source>
                <volume>36</volume>
                <fpage>714</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15220921</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.graham.2001.291">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>JM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Anyane-Yeboa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raams</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appeldoorn</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleijer</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garritsen</surname>
                    <given-names>VH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Busch</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edersheim</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>NG</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Cerebro-oculo-facio-skeletal syndrome with a nucleotide excision-repair defect and a mutated XPD gene, with prenatal diagnosis in a triplet pregnancy.</article-title>
                <source>Am J Hum Genet</source>
                <volume>69</volume>
                <fpage>291</fpage>
                <lpage>300</lpage>
                <pub-id pub-id-type="pmid">11443545</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.hadjrabia.2013.1109">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hadj-Rabia</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oriot</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soufir</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dufresne</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourrat</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mallet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulhalon</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ezzedine</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grandchamp</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ta&#x000ef;eb</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Catteau</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarasin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bodemer</surname>
                    <given-names>C.</given-names>
                  </name>
                </person-group>
                <article-title>Unexpected extradermatological findings in 31 patients with xeroderma pigmentosum type C.</article-title>
                <source>Br J Dermatol.</source>
                <year>2013</year>
                <volume>168</volume>
                <fpage>1109</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">23278166</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.heller.2015.734">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heller</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuschal</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the TTDN1 gene are associated with a distinct trichothiodystrophy phenotype.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2015</year>
                <volume>135</volume>
                <fpage>734</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">25290684</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.hirai.2006.171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hirai</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kodama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moriwaki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cullings</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macphee</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kodama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mabuchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Land</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population.</article-title>
                <source>Mutat Res.</source>
                <volume>601</volume>
                <fpage>171</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16905156</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.horibata.2004.15410">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horibata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwamoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuraoka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurimasa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oshimura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ichihashi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome.</article-title>
                <source>Proc Natl Acad Sci USA</source>
                <volume>101</volume>
                <fpage>15410</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15486090</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.imoto.2013.175">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Imoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nadem</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moriwaki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishigori</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldstein</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Ancient origin of a Japanese xeroderma pigmentosum founder mutation.</article-title>
                <source>J Dermatol Sci.</source>
                <year>2013</year>
                <volume>69</volume>
                <fpage>175</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23194742</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.inui.2008.2055">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Inui</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nadem</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gozukara</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emmert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slor</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Busch</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seitz</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gratchev</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>KY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azizi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodgate</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Xeroderma pigmentosum-variant patients from America, Europe, and Asia.</article-title>
                <source>J Invest Dermatol.</source>
                <volume>128</volume>
                <fpage>2055</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">18368133</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.itin.2001.891">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Itin</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarasin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pittelkow</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes.</article-title>
                <source>J Am Acad Dermatol</source>
                <volume>44</volume>
                <fpage>891</fpage>
                <lpage>920</lpage>
                <pub-id pub-id-type="pmid">11369901</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.itoh.1994.233">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Itoh</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ono</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaizumi</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>A new UV-sensitive syndrome not belonging to any complementation groups of xeroderma pigmentosum or Cockayne syndrome: siblings showing biochemical characteristics of Cockayne syndrome without typical clinical manifestations.</article-title>
                <source>Mutat Res.</source>
                <year>1994</year>
                <volume>314</volume>
                <fpage>233</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">7513056</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.jaspers.2007.457">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raams</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silengo</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijgers</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niedernhofer</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giglia-Mari</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoogstraten</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleijer</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoeijmakers</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeulen</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure.</article-title>
                <source>Am J Hum Genet</source>
                <volume>80</volume>
                <fpage>457</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">17273966</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.jerbi.2016.439">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jerbi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Rekaya</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naouali</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messaoud</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tounsi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chargui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kefi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boussen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mokni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mrad</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boubaker</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdelhak</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khaled</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zghal</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yacoub-Youssef</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Clinical, genealogical and molecular investigation of the xeroderma pigmentosum type C complementation group in Tunisia.</article-title>
                <source>Br J Dermatol.</source>
                <year>2016</year>
                <volume>174</volume>
                <fpage>439</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">26211814</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.kashiyama.2013.807">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kashiyama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakazawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pilz</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fawcett</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wing</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewin</surname>
                    <given-names>SO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carr</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>TS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshiura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Utani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenblatt</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGibbon</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarkany</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fassihi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagayama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsutake</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogi</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia.</article-title>
                <source>Am J Hum Genet</source>
                <volume>92</volume>
                <fpage>807</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">23623389</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.khan.2004.343">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gozukara</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inui</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shahlavi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muniz-Medina</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aiken</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk.</article-title>
                <source>Hum Mol Genet</source>
                <volume>13</volume>
                <fpage>343</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">14662655</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.khan.2002.3624">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muniz-Medina</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shahlavi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inui</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emmert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function.</article-title>
                <source>Nucleic Acids Res</source>
                <volume>30</volume>
                <fpage>3624</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">12177305</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.khan.2009.114">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emmert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shahlavi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armstrong</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuburg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zalewski</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brewer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiggs</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms.</article-title>
                <source>DNA Repair (Amst)</source>
                <volume>8</volume>
                <fpage>114</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">18955168</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.khan.2006.84">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shahlavi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Busch</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inui</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emmert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muniz Medina</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khadavi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gozukara</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slor</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarasin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Reduced XPC mRNA levels in clinically normal parents of xeroderma pigmentosum patients.</article-title>
                <source>Carcinogenesis</source>
                <volume>27</volume>
                <fpage>84</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">16081512</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.kleijer.2008.744">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kleijer</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laugel</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berneburg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fawcett</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gratchev</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarasin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy.</article-title>
                <source>DNA Repair (Amst)</source>
                <volume>7</volume>
                <fpage>744</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">18329345</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.kraemer.1988.1633">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moshell</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tarone</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peck</surname>
                    <given-names>GL</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin.</article-title>
                <source>N Engl J Med</source>
                <volume>318</volume>
                <fpage>1633</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">3287161</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.kraemer.1994.1018">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambert</surname>
                    <given-names>WC</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm.</article-title>
                <source>Arch Dermatol</source>
                <volume>130</volume>
                <fpage>1018</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">8053698</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.kraemer.1987.241">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scotto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1987</year>
                <article-title>Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases.</article-title>
                <source>Arch Dermatol</source>
                <volume>123</volume>
                <fpage>241</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">3545087</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.kraemer.2007.1388">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patronas</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship.</article-title>
                <source>Neuroscience.</source>
                <volume>145</volume>
                <fpage>1388</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">17276014</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.kraemer.2012">
              <mixed-citation publication-type="book">Kraemer KH, Ruenger T. Genome instability, DNA repair, and cancer. In: Wolff K, Katz S, Goldsmith L, Gilchrist B, Leffell D, Paller A, eds. <italic toggle="yes">Fitzpatrick&#x02019;s Dermatology in General Medicine</italic>. 8 ed. New York, NY: McGraw-Hill; 2012:1227-39.</mixed-citation>
            </ref>
            <ref id="xp.REF.kraemer.1985.33">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slor</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1985</year>
                <article-title>Xeroderma pigmentosum.</article-title>
                <source>Clin Dermatol.</source>
                <volume>3</volume>
                <fpage>33</fpage>
                <lpage>69</lpage>
                <pub-id pub-id-type="pmid">3833325</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.kuschal.2016.627">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kuschal</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Botta</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orioli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seneca</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keymolen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heller</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caligiuri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanzafame</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricotti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peverali</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephens</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baranello</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levens</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>GTF2E2 mutations destabilize the general transcription factor complex TFIIE in individuals with DNA repair-proficient trichothiodystrophy.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2016</year>
                <volume>98</volume>
                <fpage>627</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">26996949</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.lai.2013.4">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>YC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alimchandani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aung</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsokos</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hewitt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rushing</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levens</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fine</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patronas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleiner</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oberholtzer</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quezado</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>The influence of DNA repair on neurologic degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D)</article-title>
                <source>Acta Neuropathol Commun</source>
                <year>2013</year>
                <volume>1</volume>
                <fpage>4</fpage>
                <pub-id pub-id-type="pmid">24252196</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.lehmann.2001.15">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases.</article-title>
                <source>Genes Dev</source>
                <volume>15</volume>
                <fpage>15</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">11156600</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.liang.2005.224">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liang</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Price</surname>
                    <given-names>VH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menefee</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Characterization of tiger tail banding and hair shaft abnormalities in trichothiodystrophy.</article-title>
                <source>J Am Acad Dermatol</source>
                <volume>52</volume>
                <fpage>224</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">15692466</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.mahindra.2008.881">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mahindra</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brahim</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hornyak</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stern</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Driscoll</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montemarano</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugarman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Skin cancers, blindness, and anterior tongue mass in African brothers.</article-title>
                <source>J Am Acad Dermatol.</source>
                <volume>59</volume>
                <fpage>881</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19119101</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.masaki.2008.144">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Masaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ono</surname>
                    <given-names>R.</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanioka</surname>
                    <given-names>M.</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Funasaka</surname>
                    <given-names>Y.</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagano</surname>
                    <given-names>T.</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moriwaki</surname>
                    <given-names>S.</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishigori</surname>
                    <given-names>C.</given-names>
                  </name>
                </person-group>
                <article-title>Four types of possible founder mutations are responsible for 87% of Japanese patients with Xeroderma pigmentosum variant type.</article-title>
                <source>J Dermatol Sci.</source>
                <year>2008</year>
                <volume>52</volume>
                <fpage>144</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18703314</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.meira.2000.1221">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meira</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>JM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Busch</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doughty</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ziffer</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coleman</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savre-Train</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedberg</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Manitoba aboriginal kindred with original cerebro-ocular facial syndrome</article-title>
                <source>Am J Hum Genet</source>
                <volume>66</volume>
                <fpage>1221</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10739753</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.messaoud.2010.883">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Messaoud</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Rekaya</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kefi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chebel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boughammoura-Bouatay</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bel Hadj Ali</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gouider-Khouja</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zili</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frih-Ayed</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mokhtar</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdelhak</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zghal</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family.</article-title>
                <source>Br J Dermatol.</source>
                <volume>162</volume>
                <fpage>883</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20199544</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.moriwaki.2001.47">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moriwaki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Xeroderma pigmentosum--bridging a gap between clinic and laboratory.</article-title>
                <source>Photodermatol Photoimmunol Photomed.</source>
                <year>2001</year>
                <volume>17</volume>
                <fpage>47</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">11338401</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.moriwaki.2012.304">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moriwaki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takigawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Igarashi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagai</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amano</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishikawa</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Xeroderma pigmentosum complementation group G patient with a novel homozygous missense mutation and no neurological abnormalities.</article-title>
                <source>Exp Dermatol.</source>
                <year>2012</year>
                <volume>21</volume>
                <fpage>304</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22417308</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.moslehi.2010.365">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moslehi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Signore</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mills</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucker</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Troendle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldstein</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Adverse effects of trichothiodystrophy DNA repair and transcription gene disorder on human fetal development.</article-title>
                <source>Clin Genet.</source>
                <volume>77</volume>
                <fpage>365</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">20002457</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.nagore.2003.858">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nagore</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sevila</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanmartin</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Botella-Estrada</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Requena</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serra-Guillen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez-Pedreno</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guillen</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Excellent response of basal cell carcinomas and pigmentary changes in xeroderma pigmentosum to imiquimod 5% cream.</article-title>
                <source>Br J Dermatol</source>
                <volume>149</volume>
                <fpage>858</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">14616381</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.nakazawa.2012.586">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakazawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsutake</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuse</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohyama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mishima</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinoshita</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ono</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takenaka</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masuyama</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kudo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slor</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Utani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tateishi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshiura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogi</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in UVSSA cause UV-sensitive syndrome and impair RNA polymerase IIo processing in transcription-coupled nucleotide-excision repair.</article-title>
                <source>Nat Genet.</source>
                <year>2012</year>
                <volume>44</volume>
                <fpage>586</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">22466610</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.nardo.2009.6209">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nardo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oneda</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spivak</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orioli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laugel</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stary</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanawalt</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarasin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>A UV-sensitive syndrome patient with a specific CSA mutation reveals separable roles for CSA in response to UV and oxidative DNA damage.</article-title>
                <source>Proc Natl Acad Sci USA.</source>
                <year>2009</year>
                <volume>106</volume>
                <fpage>6209</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">19329487</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.nichols.1996.24317">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nichols</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ong</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linn</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Mutations specific to the xeroderma pigmentosum group E Ddb- phenotype.</article-title>
                <source>J Biol Chem.</source>
                <volume>271</volume>
                <fpage>24317</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">8798680</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.niedernhofer.2006.1038">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Niedernhofer</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garinis</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raams</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalai</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appeldoorn</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odijk</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostendorp</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Leeuwen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theil</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeulen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Horst</surname>
                    <given-names>FTJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meinecke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleijer</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vijg</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>NGJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoeijmakers</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis.</article-title>
                <source>Nature</source>
                <volume>444</volume>
                <fpage>1038</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">17183314</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.nishigori.1994.191">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nishigori</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moriwaki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takebe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imamura</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan.</article-title>
                <source>Arch Dermatol</source>
                <volume>130</volume>
                <fpage>191</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">7905727</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.oh.2011.785">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emmert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Multiple skin cancers in adults with mutations in the XP-E (DDB-2) DNA repair gene.</article-title>
                <source>J Invest Dermatol</source>
                <volume>131</volume>
                <fpage>785</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21107348</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.oh.2007.1359">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Influence of XPB helicase on recruitment and redistribution of nucleotide excision repair proteins at sites of UV-induced DNA damage.</article-title>
                <source>DNA Repair (Amst)</source>
                <volume>6</volume>
                <fpage>1359</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">17509950</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.oh.2006.1092">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raams</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedmann</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emmert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gratchev</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachlan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucassan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.</article-title>
                <source>Hum Mutat</source>
                <volume>27</volume>
                <fpage>1092</fpage>
                <lpage>103</lpage>
                <pub-id pub-id-type="pmid">16947863</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.ohto.2004.222">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwasaki</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okubo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsui</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Life-threatening vocal cord paralysis in a patient with group A xeroderma pigmentosum.</article-title>
                <source>Pediatr Neurol</source>
                <volume>30</volume>
                <fpage>222</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">15033209</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.opletalova.2014.117">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Opletalova</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourillon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pouvelle</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Despras</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludovic</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mateus</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robert</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kannouche</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soufir</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarasin</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations.</article-title>
                <source>Hum Mutat.</source>
                <year>2014</year>
                <volume>35</volume>
                <fpage>117</fpage>
                <lpage>28</lpage>
                <pub-id pub-id-type="pmid">24130121</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.ramkumar.2011.348">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ramkumar</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>CC</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Ophthalmic manifestations and histopathology of xeroderma pigmentosum: two clinicopathological cases and a review of the literature.</article-title>
                <source>Surv Ophthalmol.</source>
                <volume>56</volume>
                <fpage>348</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">21684361</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.rapi_otrin.2003.1507">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rapi&#x00107;-Otrin</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navazza</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Botta</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLenigan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bisi</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levine</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>True XP group E patients have a defective UV-damaged DNA binding protein complex and mutations in DDB2 which reveal the functional domains of its p48 product.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>12</volume>
                <fpage>1507</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">12812979</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.rapin.2000.1442">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rapin</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindenbaum</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickson</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robbins</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Cockayne syndrome and xeroderma pigmentosum.</article-title>
                <source>Neurology</source>
                <volume>55</volume>
                <fpage>1442</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11185579</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.reichrath.2007.664">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reichrath</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Sunlight, skin cancer and vitamin D: What are the conclusions of recent findings that protection against solar ultraviolet (UV) radiation causes 25-hydroxyvitamin D deficiency in solid organ-transplant recipients, xeroderma pigmentosum, and other risk groups?</article-title>
                <source>J Steroid Biochem Mol Biol</source>
                <volume>103</volume>
                <fpage>664</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17204418</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.robbins.1974.221">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Robbins</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lutzner</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Festoff</surname>
                    <given-names>BW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coon</surname>
                    <given-names>HG</given-names>
                  </name>
                </person-group>
                <year>1974</year>
                <article-title>Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair.</article-title>
                <source>Ann Intern Med</source>
                <volume>80</volume>
                <fpage>221</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">4811796</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.roseeuw.2003.30">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roseeuw</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The treatment of basal skin carcinomas in two sisters with xeroderma pigmentosum.</article-title>
                <source>Clin Exp Dermatol.</source>
                <volume>28</volume>
                <supplement>Suppl 1</supplement>
                <fpage>30</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">14616810</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.ruenger.2012">
              <mixed-citation publication-type="book">Ruenger T, DiGiovanna J, Kraemer KH. Hereditary diseases of genome instability and DNA repair. In: Wolff K, Katz S, Goldsmith L, Gilchrist B, Leffell D, Paller A, eds. <italic toggle="yes">Fitzpatrick&#x02019;s Dermatology in General Medicine</italic>. 8 ed. New York, NY: McGraw-Hill; 2012:1654-71.</mixed-citation>
            </ref>
            <ref id="xp.REF.schubert.2014.22">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schubert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalfon</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slor</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falik-Zaccai</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emmert</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Clinical utility gene card for: Xeroderma pigmentosum.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2014</year>
                <fpage>22</fpage>
                <pub-id pub-id-type="pmid">24713663</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.schwertman.2012.598">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwertman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lagarou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dekkers</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raams</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Hoek</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laffeber</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoeijmakers</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demmers</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fousteri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeulen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marteijn</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>UV-sensitive syndrome protein UVSSA recruits USP7 to regulate transcription-coupled repair.</article-title>
                <source>Nat Genet.</source>
                <year>2012</year>
                <volume>44</volume>
                <fpage>598</fpage>
                <lpage>602</lpage>
                <pub-id pub-id-type="pmid">22466611</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.sethi.2013.1279">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sethi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fawcett</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullard</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGibbon</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarkany</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fassihi</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactions.</article-title>
                <source>Br J Dermatol.</source>
                <year>2013</year>
                <volume>169</volume>
                <fpage>1279</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">23889214</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.sidwell.2006.81">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sidwell</surname>
                    <given-names>RU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandison</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wing</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fawcett</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seet</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cream</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.</article-title>
                <source>Br J Dermatol</source>
                <volume>155</volume>
                <fpage>81</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16792756</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.sollitto.1997.942">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sollitto</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Normal vitamin D levels can be maintained despite rigorous photoprotection: Six years' experience with xeroderma pigmentosum.</article-title>
                <source>J Am Acad Dermatol</source>
                <volume>37</volume>
                <fpage>942</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9418761</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.soufir.2010.1537">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Soufir</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ged</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourillon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Austerlitz</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chemin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stary</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pham</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khadir</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roume</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadj-Rabia</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouadjar</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taieb</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Verneuil</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benchiki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grandchamp</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarasin</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.</article-title>
                <source>J Invest Dermatol.</source>
                <volume>130</volume>
                <fpage>1537</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">20054342</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.stefanini.2008">
              <mixed-citation publication-type="book">Stefanini M, Kraemer KHK. Xeroderma pigmentosum. In: Ruggieri M, Pascual-Castroviejo I, Di Rocco C, eds. <italic toggle="yes">Neurocutaneous Diseases</italic>. New York, NY: Springer; 2008:771-92.</mixed-citation>
            </ref>
            <ref id="xp.REF.sugasawa.2010.29">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sugasawa</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Regulation of damage recognition in mammalian global genomic nucleotide excision repair.</article-title>
                <source>Mutat Res.</source>
                <volume>685</volume>
                <fpage>29</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">19682467</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.takahashi.2010.2481">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Endo</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugiyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iijima</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomita</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuru</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takigawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moriwaki</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>XPA gene mutations resulting in subtle truncation of protein in xeroderma pigmentosum group A patients with mild skin symptoms.</article-title>
                <source>J Invest Dermatol.</source>
                <volume>130</volume>
                <fpage>2481</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20574439</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.tamhankar.2015.16">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tamhankar</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iyer</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravindran</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kabra</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nayak</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanghavi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joshi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chennuri</surname>
                    <given-names>VS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khopkar</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <article-title>Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients.</article-title>
                <source>Indian J Dermatol Venereol Leprol.</source>
                <year>2015</year>
                <volume>81</volume>
                <fpage>16</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">25566891</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.tamura.2014.146">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Living with xeroderma pigmentosum: comprehensive photoprotection for highly photosensitive patients.</article-title>
                <source>Photodermatol Photoimmunol Photomed.</source>
                <year>2014</year>
                <volume>30</volume>
                <fpage>146</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">24417420</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.tamura.2010a.1491">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2010a</year>
                <article-title>Founder mutations in xeroderma pigmentosum.</article-title>
                <source>J Invest Dermatol.</source>
                <volume>130</volume>
                <fpage>1491</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">20463673</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.tamura.b">
              <mixed-citation publication-type="book">Tamura D, DiGiovanna JJ, Kraemer KH. Xeroderma pigmentosum. In: Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I, eds. <italic toggle="yes">Treatment of Skin Disease: Comprehensive Therapeutic Strategies</italic>. 3 ed. London, UK: Elsevier; 2010b:789-92.</mixed-citation>
            </ref>
            <ref id="xp.REF.tamura.2012.1308">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merideth</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucker</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldstein</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>K-S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarihan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Effect of mutations in XPD (ERCC2) on pregnancy and prenatal development in mothers of patients with trichothiodystrophy or xeroderma pigmentosum.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2012</year>
                <volume>20</volume>
                <fpage>1308</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">22617342</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.tamura.2011.1046">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merideth</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucker</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldstein</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moslehi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>High-risk pregnancy and neonatal complications in the DNA repair and transcription disorder trichothiodystrophy: report of 27 affected pregnancies.</article-title>
                <source>Prenat Diagn.</source>
                <year>2011</year>
                <volume>31</volume>
                <fpage>1046</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">21800331</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.tanioka.2007.1745">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tanioka</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ono</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagano</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otoshi-Honda</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takigawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inui</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyachi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moriwaki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishigori</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Molecular analysis of DNA polymerase eta gene in Japanese patients diagnosed as xeroderma pigmentosum variant type.</article-title>
                <source>J Invest Dermatol</source>
                <volume>127</volume>
                <fpage>1745</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">17344931</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.taylor.1997.8658">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broughton</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Botta</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarasin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fawcett</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harcourt</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arlett</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <article-title>Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>1997</year>
                <volume>94</volume>
                <fpage>8658</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">9238033</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.totonchy.2013.194">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Totonchy</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pantell</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zalewski</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradford</surname>
                    <given-names>PT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merchant</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nadol</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierson</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiggs</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffith</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brewer</surname>
                    <given-names>CC</given-names>
                  </name>
                </person-group>
                <article-title>Auditory analysis of xeroderma pigmentosum 1971-2012: hearing function, sun sensitivity and DNA repair predict neurological degeneration.</article-title>
                <source>Brain.</source>
                <year>2013</year>
                <volume>136</volume>
                <fpage>194</fpage>
                <lpage>208</lpage>
                <pub-id pub-id-type="pmid">23365097</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.van_steeg.1999.86">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Steeg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer.</article-title>
                <source>Mol Med Today</source>
                <volume>5</volume>
                <fpage>86</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">10200950</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.viana.2013.1230">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Viana</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seyyedi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brewer</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zalewski</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Totonchy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joseph</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nadol</surname>
                    <given-names>JB</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <article-title>Histopathology of the inner ear in patients with xeroderma pigmentosum and neurological degeneration</article-title>
                <source>Otol Neurotol.</source>
                <year>2013</year>
                <volume>34</volume>
                <fpage>1230</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23928520</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.weeda.1997.320">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weeda</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eveno</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donker</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeulen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chevallier-Lagente</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taieb</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stary</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoeijmakers</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mezzina</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarasin</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>A mutation in the XPB/ERCC3 DNA repair transcription gene, associated with trichothiodystrophy.</article-title>
                <source>Am J Hum Genet</source>
                <volume>60</volume>
                <fpage>320</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9012405</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.wilson.2016.773">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stark</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutton</surname>
                    <given-names>RE</given-names>
                  </name>
                </person-group>
                <article-title>Novel missense mutations in a conserved loop between ERCC6 (CSB) helicase motifs V and VI: Insights into Cockayne syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2016</year>
                <volume>170</volume>
                <fpage>773</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">26749132</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.yarosh.2001.926">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yarosh</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Connor</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hawk</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rafal</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group.</article-title>
                <source>Lancet</source>
                <volume>357</volume>
                <fpage>926</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11289350</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.zhang.2012.593">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horibata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saijo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishigami</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ukai</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanno</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tahara</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neilan</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honma</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nohmi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasui</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in UVSSA cause UV-sensitive syndrome and destabilize ERCC6 in transcription-coupled DNA repair.</article-title>
                <source>Nat Genet.</source>
                <year>2012</year>
                <volume>44</volume>
                <fpage>593</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22466612</pub-id>
              </element-citation>
            </ref>
            <ref id="xp.REF.zhou.2013.831">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Compe</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Egly</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiGiovanna</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Abnormal XPD-induced nuclear receptor transactivation in DNA repair disorders: trichothiodystrophy and xeroderma pigmentosum.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2013</year>
                <volume>21</volume>
                <fpage>831</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23232694</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="xp.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="xp.Author_Notes">
          <title>Author Notes</title>
          <p><bold>NIH Study 99-C-0099.</bold> Examination of Clinical and Laboratory Abnormalities in Patients with Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy is actively recruiting new patients for a study in Bethesda, MD. Click <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT00001813">here</ext-link> for more information.</p>
        </sec>
        <sec sec-type="ack" id="xp.Acknowledgements">
          <title>Acknowledgements</title>
          <p>This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research and National Human Genome Research Institute.</p>
        </sec>
        <sec id="xp.Author_History">
          <title>Author History</title>
          <p>John J DiGiovanna, MD (2011-present)Kenneth H Kraemer, MD (2003-present)Daniel J Wattendorf, MD; National Institutes of Health (2003-2008)</p>
        </sec>
        <sec id="xp.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>29 September 2016 (ma) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>13 February 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>14 February 2013 (cd) Revision: changes in testing available for <italic toggle="yes">POLH</italic>, <italic toggle="yes">ERCC3</italic>, <italic toggle="yes">XPA</italic>, <italic toggle="yes">XPC</italic>, and <italic toggle="yes">DDB2</italic></p>
            </list-item>
            <list-item>
              <p>1 November 2012 (cd) Revision: testing for <italic toggle="yes">ERCC4</italic> mutations available clinically; <xref ref-type="fig" rid="xp.F2">Figure 2</xref> added</p>
            </list-item>
            <list-item>
              <p>15 March 2012 (cd) Revision: sequence analysis available clinically for <italic toggle="yes">ERCC1</italic> and <italic toggle="yes">ERCC3</italic> and no longer available for <italic toggle="yes">DDB2</italic></p>
            </list-item>
            <list-item>
              <p>4 August 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>22 April 2008 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>14 May 2007 (cd) Revision: sequence analysis clinically available for <italic toggle="yes">XPA</italic> and <italic toggle="yes">XPC</italic></p>
            </list-item>
            <list-item>
              <p>1 June 2006 (cd) Revision: confirmation of <italic toggle="yes">XPA</italic> and <italic toggle="yes">XPC</italic> mutations identified in a research lab clinically available</p>
            </list-item>
            <list-item>
              <p>15 September 2005 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>24 February 2004 (kk) Revision: Molecular Genetics</p>
            </list-item>
            <list-item>
              <p>1 October 2003 (kk) Revision: clinical testing no longer available</p>
            </list-item>
            <list-item>
              <p>20 June 2003 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>28 April 2003 (kk) Original submission</p>
            </list-item>
          </list>
          <p>Note: Pursuant to 17 USC Section 105 of the United States Copyright Act, the <italic toggle="yes">GeneReview</italic> &#x02018;Xeroderma Pigmentosum&#x02019; is in the public domain in the United States of America.</p>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="xp.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Relationship between genotype and phenotype in the xeroderma pigmentosum-Cockayne syndrome-trichothiodystrophy spectrumItalicized letters in ovals indicate mutated genes. Rectangles are phenotypes. Because of the complexity of the relationship, it is difficult to predict an individual&#x02019;s phenotype based on the associated gene, in part because specific pathogenic variants have different effects on the overall DNA repair/transcription pathways. From <xref ref-type="bibr" rid="xp.REF.digiovanna.2012.785">DiGiovanna &#x00026; Kraemer [2012]</xref></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="xp-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="xp.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>Nucleotide excision repair (NER) pathwayModified from <xref ref-type="bibr" rid="xp.REF.digiovanna.2012.785">DiGiovanna &#x00026; Kraemer [2012]</xref></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="xp-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
